research article spread of tem, vim, shv, and ctx-m...
TRANSCRIPT
Research ArticleSpread of TEM VIM SHV and CTX-M 120573-Lactamasesin Imipenem-Resistant Gram-Negative Bacilli Isolatedfrom Egyptian Hospitals
El sayed Hamdy Mohammed1 Ahmed Elsadek Fakhr2 Hanan Mohammed El sayed2
Said abd Elmohsen Al Johery2 and Wesam Abdel Ghani Hassanein1
1Department of Botany Faculty of Science Zagazig University Zagazig 44511 Egypt2Department of Medical Microbiology amp Immunology Faculty of Medicine Zagazig University Zagazig 44511 Egypt
Correspondence should be addressed to El sayed Hamdy Mohammed anashamdy25yahoocom
Received 26 August 2015 Revised 9 December 2015 Accepted 14 December 2015
Academic Editor Giuseppe Comi
Copyright copy 2016 El sayed Hamdy Mohammed et al This is an open access article distributed under the Creative CommonsAttribution License which permits unrestricted use distribution and reproduction in any medium provided the original work isproperly cited
Carbapenem-resistant Gram-negative bacilli resulting from 120573-lactamases have been reported to be an important cause ofnosocomial infections and are a critical therapeutic problem worldwideThis study aimed to describe the prevalence of imipenem-resistant Gram-negative bacilli isolates and detection of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHV 119887119897119886CTX-M-1 and 119887119897119886CTX-M-9 genes in these clinicalisolates in Egyptian hospitals The isolates were collected from various clinical samples identified by conventional methods andconfirmed by API 20E Antibiotic susceptibility testing was determined by Kirby-Bauer technique and interpreted according toCLSI Production of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHV and 119887119897119886CTX-M genes was done by polymerase chain reaction (PCR) Direct sequencingfrom PCR products was subsequently carried out to identify and confirm these 120573-lactamases genes Out of 65 isolates (461)Escherichia coli (262) Klebsiella pneumoniae and (107) Pseudomonas aeruginosa were identified as the commonest Gram-negative bacilli 33(508) were imipenem-resistant isolates 22 isolates (667) carried 119887119897119886VIM 24(727) had 119887119897119886TEM and 5(15)showed 119887119897119886SHV while 12(36) 6(182) and 0(000) harbored 119887119897119886CTX-M-1 119887119897119886CTX-M-9 and 119887119897119886CTX-M-825 respectively There is ahigh occurrence of 120573-lactamase genes in clinical isolates and sequence analysis of amplified genes showed differences betweenmultiple SNPs (single nucleotide polymorphism) sites in the same gene among local isolates in relation to published sequences
1 Introduction
Gram-negative bacilli are a heterogeneous group of Gram-negative bacteria that are common commensals infectiousagents and also sometimes referred to as ldquonightmare bacteriardquo[1] Hospital acquired infections due to Gram-negative bacilliare a leading cause of morbidity andmortality worldwide [2]
Carbapenem a member of the 120573-lactam family has abroad spectrum of activity and is stable tomost 120573-lactamasesThese properties make carbapenem an important therapeu-tic option for treating serious infections involving resis-tant strains of Enterobacteriaceae anaerobes Pseudomonasaeruginosa and Acinetobacter spp [3] although carbapen-ems including imipenem and meropenem are often usedas ldquoantibiotics of last resortrdquo when patients with infections
become severely ill or are suspected of harboring resistantbacteria [4] However carbapenem-resistant Gram-negativebacilli isolates were increasingly reported worldwide [5]
This resistance may be attributed to presence of metallo-120573-lactamase in bacteria such as IMP (Imipenemase) VIM(Verona-Integron metallo-120573-lactamase) [6] and extendedspectrum 120573-lactamases (ESBLs) such as SHV TEM andCTX-M [7]
For establishment of appropriate antimicrobial therapyand control of the spread of drug resistant Gram-negativebacilli the PCR-based detection methods of resistant genesshow the bioinformatics analysis of their molecular diversityand evolution becoming increasingly important [8]
This work aimed to study distribution of imipenem-resistant Gram-negative isolates and shed focused light on
Hindawi Publishing CorporationInternational Journal of MicrobiologyVolume 2016 Article ID 8382605 15 pageshttpdxdoiorg10115520168382605
2 International Journal of Microbiology
Table 1 Primer name primer sequences and expected amplicon size of amplified DNA products
PCR name 120573-lactamase targeted Primer name Sequence (51015840-31015840) Amplicon size (bp)
VIM VIM variants including VIM-1 andVIM-2
VIM-for GATGGTGTTTGGTCGCATA 390VIM-rev CGAATGCGCAGCACCAG
TEM TEM variants including TEM-1 andTEM-2
TSO-T-for CATTTCCGTGTCGCCCTTATTC 800TSO-T-rev CGTTCATCCATAGTTGCCTGAC
SHV SHV variants including SHV-1 TSO-S-for AGCCGCTTGAGCAAATTAAAC 713TSO-S-rev ATCCCGCAGATAAATCACCAC
CTX-Mgroup 1
Variants of CTX-M group 1 includingCTX-M-1 CTX-M-3 and CTX-M-15
CTXMGp 1-for TTAGGAARTGTGCCGCTGYAb688
CTXMGp 12 rev CGATATCGTTGGTGGTRCCATb
CTX-Mgroup 9
Variants of CTX-M-9 includingCTX-M-9 and CTX-M-14
CTX-9-F TCAAGCCTGCCGATCTGGT 561CTX-9-R TGATTCTCGCCGCTGAAG
CTX-Mgroup 825
CTX-M-8 CTX-M-25 CTX-M-26 andCTX-M-39 to CTX-M-41
CTX-825-F AACRCRCAGACGCTCTACb326
CTX-825-R TCGAGCCGGAASGTGTYATb
bY = T or C R = A or G S = G or C
some genes encoding beta-lactamase enzymes responsible forsuch resistance in Zagazig University Hospitals in Egypt
2 Material and Methods
21 Bacterial Isolates Clinical isolates of Gram-negativebacilli including Escherichia coli (119899 = 30) Klebsiella pneu-moniae (119899 = 17) Pseudomonas aeruginosa (119899 = 7) Proteusmirabilis (119899 = 2) Citrobacter freundii (119899 = 1) Acinetobacterbaumanii (119899 = 3) and Enterobacter cloacae (119899 = 4) werecollected fromblood urine pus and sputum specimens fromhospitalized patients in ZagazigUniversityHospitals in Egyptfrom January 2013 toMarch 2014These clinical samples wereprocessed by plating on blood agar and MacConkey agar[9] A growth temperature of 44∘C was used sometimes toconfirm the identity of these isolates and the identified strainswere stored in glycerol (20 VV) at 70∘C and subculturedseveral times to be viable All isolates were identified bystandard biochemical tests [10] and confirmed by API 20E(BioMerieux Marcy lrsquoEtoile France)
22 Antibiotic Susceptibility Testing The susceptibility testingof studied isolates was performed by disc diffusion method(modified Kirby-Bauer method) using Muller-Hinton agar(Becton Dickinson MA USA) and interpreted accordingto the Clinical Laboratory Standard Institute (CLSI) guide-lines [11] The antibiotic disks used imipenem (IPM 10 120583g)amikacin (AK 30 120583g) ciprofloxacin (CIP 5 120583g) piperacillin(PRL 100 120583g) cefoperazonesulbactam (CES 10 + 5 120583g)cefoxitin (FOX 30 120583g) and cefotaxime (CTX 30120583g) whichwere placed 15mm away from the central disc and the plateswere incubated for about 18ndash24 hrs at 37∘C
23 Molecular Detection of 120573-Lactamase Genes by PCR Fordetection of 120573-lactamase genes responsible for imipenem-resistance rapid genomic DNA was prepared from aboutfive colonies heated in 100mL distilled water (95∘C for10min) followed by a centrifugation step of cell suspension at
12000 rpm for 5min then supernatant was taken as a sourceof template DNA PCR amplification was carried out by usingDNA thermal cycler (Biometra Singapore) using a specificprimer for 119887119897119886VIM 119887119897119886TEM 119887119897119886SHV 119887119897119886CTX-M-1 119887119897119886CTX-M-9and 119887119897119886CTX-M-825 (Table 1) in a 50120583L volume containing 10xPCR buffer 2mM deoxynucleoside triphosphates 34 pmolof each primer 25mM MgCl
2 1 U Taq DNA polymerase
and 1 120583L of genomic DNA [12] Amplification was carriedout as follows initial denaturation at 94∘C for 10 minutesfollowed by 40 cycles of DNA denaturation at 94∘C for40 seconds primer annealing at 60∘C for 40 seconds andprimer extension at 72∘C for 1 minute and a final elongationstep at 72∘C for 7 minutes The annealing temperature wasoptimal at 55∘C instead of 60∘C for amplification of 119887119897119886VIMAmplicons were then visualized after running in 2 agarosegel at 100V for 30mins A 50ndash1000 bpDNA ladder (USA)wasused as a size marker Finally PCR products were purifiedwith innuPREP PCRpure kit (Analytik Jena Germany) andsubjected to direct sequencing via GATC Company by use ofABI 3730xl DNA sequencer
24 Bioinformatics and Sequences Analysis The obtainedchromatogram sequencing files were inspected and correctedusing the software application Chromas 23 (TechnelysiumHelensvale Australia) and JalView (28)
The sequences obtained from our samples were alignedwith GenBank sequences The phylogenetic tree for eachsequence was obtained by performing neighbor-joining anal-ysis of the alignment of sequences with reference strains(accession numberscountry of origin) that were retrievedfrom GenBank The studied strains were marked by the sign[◼] Meanwhile the reference sequences were marked by thesign [998771]
The BLAST and FASTA programs of the National Centerfor Biotechnology Information (httpblastncbinlmnihgovBlastcgi) were used to search databases for similarnucleotide sequences [13] Multiple sequence alignments ofthe nucleic acidwere carried out using theClustalWprogramThe statistical analysis was performed using SPSS version
International Journal of Microbiology 3
477
615538
231323
184
015 15 46 92 610 0
508446 415
677615
815
100
SusceptibleIntermediateResistant
0102030405060708090
100
()
Imip
enem
Am
ikac
in
Cipr
oflox
acin
Pipe
raci
llin
Cef
oxiti
n
Cef
otax
ime
Cef
oper
azon
e(s
ulba
ctam
)
Figure 1 Antimicrobial susceptibility patterns of all 65 Gram-negative bacilli isolates
2001205942 = chi-square test and119875 valueslt 005were consideredsignificant
3 Results
31 Isolation and Identification The present study was con-ducted on 65 screened isolates of Gram-negative bacilliobtained from 108 various clinical samples such as urineblood pus and sputum where 41 (788) were isolatedfrom urine 12 (666) from blood 14 (482) from respi-ratory secretions and 2 (222) from pus Escherichia coli(461) was the most commonly isolated organism amongGram-negative bacilli followed by Klebsiella pneumoniae(262) Pseudomonas aeruginosa (107) Enterobacter cloa-cae (61) Proteus mirabilis (307) and Acinetobacter bau-manii (46) while Citrobacter freundii and Proteus vulgarisgave 15 The isolation of Gram-negative bacilli isolates wassignificantly higher in patients with trauma (119875 lt 0001)those hospitalized for more than 7 days (119875 lt 0001) andthose with ICU admission (119875 lt 0001) harboring risk factorsfor acquiring Gram-negative bacilli infection
32 The Antibiotic Susceptibility Testing It was shown inFigure 1 as observed that 40 (615) were susceptibleto amikacin 35 (538) were susceptible to ciprofloxacin31 (477) were susceptible to imipenem and 21 (323)were susceptible to cefoperazonesulbactam However allisolates were resistant to cefotaxime (100) 53 (815) ofisolates were resistant to cefoxitin 44 (677) were resis-tant to piperacillin 40 (615) were resistant to cefoper-azonesulbactam 33 (508) were resistant to imipenemfollowed by 24 (446) resistant to amikacin and 27 (415)were resistant to ciprofloxacin
33 PCRAssay Results As shown in Table 6 of 33 imipenem-resistant Gram-negative bacillistrains the results of PCR
amplification products of 120573-lactamases genes showed that667 of isolates carried 119887119897119886VIM at 390 bp (Figure 2(a))727 had 119887119897119886TEM at 800 bp (Figure 2(b)) 360 harbored119887119897119886CTX-M-1 at 688 bp (Figure 2(c)) and 150 showed 119887119897119886SHV(Figure 2(d)) while 182 (Figure 2(e)) 000 (Figure 2(f))harbored 119887119897119886CTX-M-9 119887119897119886CTX-M-825 respectively Sequencingconfirmed presence of these 120573-lactamase genes the GenBanknucleotide sequence accession numbers for the sequencesstudied are detailed Aligning of the obtained sequences withthose of reference strains in GenBank confirmed the correctidentification of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHV and 119887119897119886CTX-M genesby PCR
34 Sequences Analysis and Polymorphism
341 The Analysis of VIM Gene (119887119897119886VIM12) The sequence ofthe purified product of VIM gene (119887119897119886VIM12) was comparedwith homologousGenBank sequences using BLAST programand resulted in significant similarity to many metallo-120573-lactamases genes of different bacterial strains
(1) VIM Gene (blaVIM12) in Escherichia coli Strains The pair-wise sequences alignments of resulting VIM gene (119887119897119886VIM12)in E coli strains isolated from Zagazig University (ZU)Hospitals in comparison with published VIM gene in Ecoli strains from GenBank for example (E coli KC4173771)showed single common SNP (single nucleotide polymor-phism) sites between the different strains The SNPs posi-tion was indicated in position 382 in the Egyptian strains(Figure 3(a))The phylogenetic tree of VIM gene sequence inE coli strains isolated fromZagazigUniversityHospitals andpublished homologous sequences in GenBank showed dif-ferent degrees of dissimilarity between the different strains(Figure 3(b)) It was interesting to detect that both strainsthe most similar and most dissimilar strains were from thesame country Greece indicating biodiversity in the samegeographical location
(2) VIMGene (blaVIM12) in Klebsiella pneumoniae StrainsTheVIM gene isolated from K pneumoniae strains in ZagazigUniversity Hospitals was comparedwith publishedVIM genein K pneumoniae strains from GenBank (eg K pneumoniaeDQ1439131) The results showed 6 different common SNPsbetween the different strains The SNPs positions were indi-cated in 45 150 168 284 309 and 363 (Figure 3(c)) Thephylogenetic tree of VIM gene sequence in K pneumoniaestrains isolated from ZU Hospitals and published homol-ogous sequences in GenBank showed different degrees ofdissimilarity between the different strains with many uniquesequences in the Egyptian strain (Figure 3(d))
(3) VIM Gene (blaVIM12) in Acinetobacter baumanii StrainsThe sequence of purified product of VIM gene (119887119897119886VIM12)from Acinetobacter baumanii strain was compared with theGenBank sequence using BLAST program Interestingly itwas revealed that therewas a single strain present inGenBankwhich is completely different from the studied strains andthis is notmatchingwith our study (eg Staphylococcus phageStB12 complete genome) The sequence alignment showed 9
4 International Journal of Microbiology
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
390
(a)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
800
(b)1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
688
(c)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
713
(d)1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
561
(e)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
326
(f)
Figure 2 Presence and absence of 120573-lactamase genes by PCR amplification in some isolated samples (a)The existence of VIM amplificationfragment (390 bp) (b) The amplification of TEM fragments (800 bp) (c) The amplification of CTX-M-1 (688 bp) (d) The presence of SHV(713 bp) in some samples (e) The presence of CTX-M-9 (561 bp) (f) No amplification was shown with CTX-M-825 primer at 326 bp
different common SNPs between the different strains Thesepositions were indicated in 246 284 306 309 330 363 378382 and 383 (Figure 3(e)) The phylogenetic tree of VIMsequence of A baumanii isolated from ZU Hospitals andpublished ones in GenBank showed dissimilarity betweenEgyptian strains and others (Figure 3(f))
342 Sequence Analysis of TEM Gene (119887119897119886VIM12) Sequencesof the purified product of VIM gene (119887119897119886VIM12) were com-paredwith homologous counterpartGenBank database using
BLASTprogramand resulted in significant similarity tomanymetallo-120573-lactamases genes of different bacterial strains
(1) TEM Gene (blaTEM12) of Escherichia coli The TEM genesequences of E coli strains isolated from ZU Hospitalswere aligned with sequences of published TEM genes in Ecoli strains from GenBank (eg E coli KM5986651) Theresulting alignments showed 4 different common SNP sitesbetween the different strains The SNPs positions were indi-cated commonly in 216 232 385 and 433 (Figure 4(a)) Phy-logenetic tree was constructed from TEM gene (119887119897119886TEM12)
International Journal of Microbiology 5
AM_372945-22_2-group16-_Vim-group16-_H031-316gi1-390
Consensus
152227
264339
AM_372945-22_2-group16-_Vim-group16-_H031-316gi1-390
Consensus
265340
316390
(a)
AM 372945-22-2-group16-Vim-group16-H03 Ecoli Egypt0000
0000
0000
117376
117339
0037
20
KC4173771
gi Escherichia coli (blaVIM-1) EF0786971 Greece
gi Escherichia coli (blaVIM-1) GU7248711 France
gi Escherichia coli (blaVIM-2) gene KF8566171 Spaingi Escherichia coli blaVIM-1 gene AY7814131 Greece
(b)1111111111
121121121121121121121121121121
361361361361361361361361361361
241241241241241241241241241241
120120120120120120120120120120
240240240240240240240240240240
390390390390390390390390390390
360360360360360360360360360360
Consensus
Consensus
Consensus
Consensus
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
(c)
gi Klebsiella pneumoniae VIM-2 genes |DQ1532171| Koreagi| Klebsiella pneumoniae strain (VIM-1) |GQ4228371| USA
gi Klebsiella pneumoniae plasmid|NG 0362531| USAAM 372945-24 4-group16-Vim-group16-H03 Kpneumonia Egypt
000
0011
00040002
000900090009
DQ1439131
0008 0006 0004 0002 00000010Relative times
gi Klebsiella pneumoniae strain (blaVIM-1) |GQ4228271| USA
(d)
Figure 3 Continued
6 International Journal of Microbiology
168168184168168243243
289289305289289364364
288288304288288363363
317315331315315390390
Consensus
Consensus
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
(e)
gi Acinetobacter baumannii VIM-1 |EF6906951| Greece
AM 372945-23 3-group16-Vim-group16-G03 Abaumanii Egypt0556
0009
0000
00000011
0542
0006
01
JN7005202
gi A baumannii class I integron (blaVIM-1) |EF6906961| Greece
gi Acinetobacter baumannii strain VIM (blaVIM) |JF7029211| India
gi Acinetobacter baumannii strain (blaVIM) |JF7029191| India
(f)
Figure 3Themultiple sequences alignments and trees of VIM gene in different species (a) VIM gene in E coli strains isolated from ZagazigUniversity (ZU) Hospitals in comparison with published VIM gene of E coli strains from GenBank (b) A tree of VIM sequence of E coliisolated from ZU Hospitals and published homologs in GenBank (c) The multiple sequences alignments of VIM gene in K pneumoniaestrains isolated from ZUHospitals in comparison with published VIM gene inK pneumoniae strains fromGenBank (d) Phylogenetic tree ofVIM sequence of K pneumoniae isolated from ZUHospitals and published sequences in GenBank (e)Themultiple sequences alignments ofVIM gene in A baumanii strains isolated from ZUHospitals in comparison with published VIM gene in A baumanii strains from GenBank(f) Phylogenetic tree of VIM sequence of A baumanii isolated from ZU Hospitals and published sequences in GenBank
sequence of Escherichia coli strains isolated from ZU Hos-pitals and published homologous sequences in GenBank(Figure 4(b)) showing similarity degree between Egyptianand Indian strains
(2) TEM Gene (blaTEM12) of Klebsiella pneumonia Multiplesequences alignments of TEM gene inK pneumoniae strainsisolated from ZU Hospitals were compared with other pub-lished TEM genes in K pneumoniae strains from GenBank(eg K pneumoniae KF2683571) (Figure 4(c)) showed 2different common SNPs between different strains The SNPspositions were indicated in 174 and 343 A phylogenetictree of TEM sequence of K pneumoniae isolated fromZagazig University Hospitals and other published ones inGenBank showed the degree of similarity between strainswhere Egyptian strain was dissimilar to that of Iranian andIndian strains (Figure 4(d))
343 The Analysis of SHV Gene (119887119897119886SHV1) in Klebsiellapneumoniae Strains The pairwise sequences alignments ofresulting SHV gene (119887119897119886SHV1) in K pneumoniae strains iso-lated from Zagazig University Hospitals in comparison withpublished SHV gene inK pneumoniae strains fromGenBankusing BLAST program (eg K pneumoniae AF1249841)
showed five common SNPs between the different strainsTheSNPs position was indicated in 454 563 631 635 and 650in Egyptian strains (Figure 5(a)) The phylogenetic tree ofSHV gene in this case showed that Egyptian strain was moresimilar to France strain (Figure 5(b))
344The Analysis of CTX-M-1 Gene (119887119897119886CTX-M-1) Sequencesof the purified product of CTX-M-1 gene (119887119897119886CTX-M-1) werecompared with homologous counterpart GenBank databaseusing BLAST program and resulted in significant similarityto many metallo-120573-lactamases genes of different bacterialstrains
(1) CTX-M-1 Gene (blaCTX-M-1) of Escherichia coli Strains Thesequence of the purified product of CTX-M-1 gene fromEscherichia coli strains was compared with the GenBanksequence using BLASTprogram Interestingly it was revealedthat there were strains present in GenBank which are com-pletely different from the studied strains and this is notmatchingwith our study (egPseudomonas aeruginosaDNAAP0146461) The sequence alignment showed 81 differentcommon SNPs between the different strains The SNPspositions were indicated in 601 604rarr 615 617rarr 626 and628rarr 688 (Figure 6(a)) The phylogenetic tree of CTX-M-1
International Journal of Microbiology 7
91115115115
205229229229
319343343343
433457457457
547571571571
204228228228
318342342342
432456456456
546570570570
660684684684
Consensus
Consensus
Consensus
Consensus
Consensus
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
(a)
TEM Ecoli Egypt
00041
0002700000
00014
00005
KM5986651gi|675594620|gb|KJ9230021| Escherichia coli strain blaTEM (blaTEM-1) India
gi|383282208|gb|JQ8231751| Escherichia beta-lactamase TEM (blaTEM) India
gi|347810716|gb|JN1883651| Escherichia coli strain ARY 4 blaTEM gene India
(b)115102111111111111111
229216225225225225225
343330339339339339339
228215224224
342329338338338338338
456443452452452452452
224224224
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
Consensus
Consensus
Consensus
(c)
AM 372945-26 6-group16-T-group16-B04 Kpneumonia Egypt00022
00033
00000
00000
00000
00000
00000
0001500004
00015
00005
00005
KF2683571gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346951| Iran
gi Klebsiella pneumoniae beta-lactamase TEM-1 (blaTem) |GQ4704601| Irangi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |GU7346961| Iran
gi Klebsiella pneumoniae strain TEM-1 (blaTem) gene |GU7346941| Iran
gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346901| Iran
gi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |JN0433841| India
(d)
Figure 4 The multiple sequences alignments and trees of TEM gene (119887119897119886TEM12) in different bacterial species (a) TEM gene in E coli strainsisolated fromZUHospitals in comparisonwith publishedTEMgene ofE coli strains fromGenBank (b)Aphylogenetic tree of TEMgene ofEcoli isolated fromZUHospitals and published homologous ones inGenBank (c)Themultiple sequences alignments of gene inK pneumoniaestrains isolated from ZU Hospitals in comparison with published TEM gene in K pneumoniae strains from GenBank (d) Phylogenetic treeof sequence of K pneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
8 International Journal of Microbiology
340
340340340340
340340
453
453453453453
453453
566
566566566566
566566
324
324324
211
211211
98
9898
452
452452452452
452452
210
210210
565
565565565
565565
565
323
323323
678
678678678678
678678
436
436436
Consensus
Consensus
Consensus
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
(a)
gi Klebsiella pneumoniae conjugative plasmid beta-lactamase SHV-13 (bla) gene |AF1645771| UK
AM_372945-30 13-group16-T-group16-A04 Ecloacae Egypt
gi Klebsiella pneumoniae beta-lactamase SHV-14 (bla) gene |AF2266221| UK
00000
00022
00087
00022
00000
00000
000000004300000
0002200022
00022
00022
00000
0001
AF1249841
gi Klebsiella pneumoniae extended spectrum beta-lactamase SHV-1 (blaSHV) gene |HM0605401| Iran
gi Klebsiella pneumoniae strain K16R SHV-1 beta-lactamase (blaSHV) gene |HM7511021| Brazil
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-11 (blaSHV) |GQ4704281| Iran
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-1 (blaSHV) |HM0605381| Iran
gi Klebsiella pneumoniae plasmid blaSHV gene for beta-lactamase SHV |AB6757231| Japan
gi Klebsiella pneumoniae blaSHV type 1 gene complete cds|DQ3557841| Brazil
gi Klebsiella pneumoniae blaSHV gene for beta-lactamase class A |Y110691| France
(b)
Figure 5Themultiple sequences alignments and trees of SHV gene in different species (a) SHV gene inK pneumoniae strains isolated fromZUHospitals in comparison with published SHV gene of K pneumoniae strains from GenBank (b) Phylogenetic tree of SHV sequence of Kpneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
sequence of E coli isolated fromZagazig University Hospitalsand published homologous ones in GenBank showed dissim-ilarity degree between Egyptian and other universal strains(Figure 6(b))
(2) CTX-M-1 Gene (blaCTX-M-1) of Klebsiella pneumoniaeStrains The alignment in this case showed 39 differentcommon SNPs between the different strains The SNPspositions were indicated in positions 1 rarr 39 (Figure 6(c))A phylogenetic tree of CTX-M-1 gene sequence in K pneu-moniae strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed different degrees
of dissimilarity between the different strains with manyunique sequences in Egyptian strain (Figure 6(d))
(3) CTX-M-1 Gene (blaCTX-M-1) of Pseudomonas aeruginosaStrainsTheCTX-M-1 gene isolated fromP aeruginosa strainsin Zagazig University Hospitals was compared using BLASTprogram with published CTX-M-1 gene in P aeruginosastrains from GenBank (eg Paeruginosa KC5712551) Theresults showed 4 different common SNPs between the differ-ent strainsThe SNPs positions were indicated in 117 206 228and 283 (Figure 6(e)) A phylogenetic tree showed similaritydegree between Egyptian and Russian strains (Figure 6(f))
International Journal of Microbiology 9
601601601601
629688688688
Consensus
CTX11-629gi|695214033|ref|NG_0367291|1-688gi|224696954|emb|FM2133711|1-688gi|402795953|dbj|AB7015731|1-688
(a)
CTX1 Ecoli Egypt05168
00000
00000
0000005168
01
AP0146461
gi |NG 0367291| Escherichia coli blaCTX-M-3 gene for beta-lactamase USA
gi Escherichia coli DNA ISEcp1-blaCTX-M-15 |AB7015731| Japan
gi Escherichia coli blaCTX-M-3 gene for beta-lactamase |FM2133711| Poland
(b)227
2911
340142
3391417474
452254187187
7575
Consensus
Consensus
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
(c)
gi Klebsiella pneumoniae strain 285L extended spectrum beta-lactamase CTX-M-15 |GQ4704351|Iran
CTX1 Klebsiella pneumoniae Egyptgi Klebsiella pneumoniae strain 212L extended spectrum beta-lactamase CTX-M-15 |GQ4704311| Irangi Klebsiella pneumoniae CTX-M-15|GQ8655681| India
00000
0000000000
07585
07515
00070
02
KJ4514101
gi Klebsiella pneumoniae (blaCTX-M-15) gene |EU5567551|Hungary
(d)56
113113
167224224
279336336
391448448
168225225
280337337
Consensus
Consensus
Consensus
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
(e)
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia(2)CTX1 Pseudomonas aeruginosa Egypt00024
00000
0000000024
00005
KC5712551
(f)
Figure 6 The multiple sequences alignments and trees of CTX-M-1 gene in different species (a) CTX-M-1 gene in E coli strains isolatedfrom ZU Hospitals in comparison with published CTX-M-1 gene of E coli strains from GenBank (b) A tree of CTX-M-1 sequence of E coliisolated from ZUHospitals and published homologs in GenBank (c)Themultiple sequences alignments of CTX-M-1 gene in K pneumoniaestrains isolated from ZU Hospitals in comparison with published CTX-M-1 gene in K pneumoniae strains from GenBank (d) Phylogenetictree of CTX-M-1 sequence of K pneumoniae isolated from ZU Hospitals and published homologous sequences in GenBank (e) Multiplesequences alignments of CTX-M-1 gene in P aeruginosa strains isolated from ZU Hospitals in comparison with published CTX-M-1 gene inP aeruginosa strains from GenBank (f) Phylogenetic tree of CTX-M-1 sequence of P aeruginosa isolated from ZU Hospitals and publishedhomologs in GenBank
10 International Journal of Microbiology
11111
113113113113113
225225225225225
Consensus
Consensus
Consensus
112112112112112
224224224224224
336336336336336
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
(a)
00000
00000
00037
00037
00005
JN6768431
AM 372945-35 21-group16- g9-group16- C05 (830bp) Ecoli Egypt
gi Escherichia coli (blaCTX-M-9b) gene complete cds |EU4189151|Australia
gi Escherichia coli strain K-340 (blaCTX-M-9) gene complete cds |HM5697351|Russia
gi Escherichia coli DNA blaCTX-M-14 gene |AB9765961|Japan
(b)
Figure 7Themultiple sequences alignments and tree of CTX-M-9 gene in different species (a) CTX-M-9 gene in E coli strains isolated fromZU Hospitals in comparison with published CTX-M-9 gene of E coli strains from GenBank (b) Phylogenetic tree of CTX-M-9 sequence ofE coli isolated from ZU Hospitals and published homologous ones in GenBank
345 The Analysis of CTX-M-9 Gene (119887119897119886CTX-M-9) inEscherichia coli Strains The CTX-M-9 gene isolated fromE coli strains in Zagazig University Hospitals was comparedwith published CTX-M-1 gene in P aeruginosa strains fromGenBank using BLAST program (eg E coli JN6768431)The multiple sequences alignments showed 2 differentcommon SNPs in positions 74 and 272 (Figure 7(a))The phylogenetic tree of CTX-M-9 gene sequence in Ecoli strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed differentdegrees of dissimilarity between the different strains andmany unique sequences in the Egyptian strain similar tothat of Russia and Australia and dissimilar to that of Japan(Figure 7(b))
4 Discussion
The Gram-negative bacilli are among the most importantcauses of serious nosocomial and community-onset bacte-rial infections in humans and antimicrobial resistance hasbecome a global threat to effective health care delivery [14]However carbapenem-resistant Gram-negative bacilli havebeen increasingly reported worldwide [4] Various acquiredcarbapenemases have been identified in the last years belong-ing to either acquired metallo-beta-lactamases (IMP VIM
Table 2 The distribution of Gram-negative bacilli isolates in eachclinical specimen
Clinical specimens Gram-negative bacilli isolatesType Number Number ()Urine 52 41 788Blood 18 12 666Sputum 29 10 345Pus 9 2 222Total 108 65 (602)1205942= 2128 119875 lt 0001 (statistically significant)
SPM GIM NDM andDIM types) or class A (KPC andGES)and class D 120573-lactamase OXA-48 [15]
In the present study prevalence of 120573-lactamases-producing isolates was found in Table 2 Different studiescarried out by other workers in various parts of the worldshow quite variable results In a study carried out thefrequency of beta-lactamases-producing isolates was urine(61) followed by blood cultures (38) wound swabs (13)and tracheal aspirates (5) (119875 lt 0001) [16] And this issimilar to our study By contrast Shanthi and Sekar [17] inIndia reported that Gram-negative isolates were obtainedfrom the respiratory tract (418) followed by urinary tract
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
2 International Journal of Microbiology
Table 1 Primer name primer sequences and expected amplicon size of amplified DNA products
PCR name 120573-lactamase targeted Primer name Sequence (51015840-31015840) Amplicon size (bp)
VIM VIM variants including VIM-1 andVIM-2
VIM-for GATGGTGTTTGGTCGCATA 390VIM-rev CGAATGCGCAGCACCAG
TEM TEM variants including TEM-1 andTEM-2
TSO-T-for CATTTCCGTGTCGCCCTTATTC 800TSO-T-rev CGTTCATCCATAGTTGCCTGAC
SHV SHV variants including SHV-1 TSO-S-for AGCCGCTTGAGCAAATTAAAC 713TSO-S-rev ATCCCGCAGATAAATCACCAC
CTX-Mgroup 1
Variants of CTX-M group 1 includingCTX-M-1 CTX-M-3 and CTX-M-15
CTXMGp 1-for TTAGGAARTGTGCCGCTGYAb688
CTXMGp 12 rev CGATATCGTTGGTGGTRCCATb
CTX-Mgroup 9
Variants of CTX-M-9 includingCTX-M-9 and CTX-M-14
CTX-9-F TCAAGCCTGCCGATCTGGT 561CTX-9-R TGATTCTCGCCGCTGAAG
CTX-Mgroup 825
CTX-M-8 CTX-M-25 CTX-M-26 andCTX-M-39 to CTX-M-41
CTX-825-F AACRCRCAGACGCTCTACb326
CTX-825-R TCGAGCCGGAASGTGTYATb
bY = T or C R = A or G S = G or C
some genes encoding beta-lactamase enzymes responsible forsuch resistance in Zagazig University Hospitals in Egypt
2 Material and Methods
21 Bacterial Isolates Clinical isolates of Gram-negativebacilli including Escherichia coli (119899 = 30) Klebsiella pneu-moniae (119899 = 17) Pseudomonas aeruginosa (119899 = 7) Proteusmirabilis (119899 = 2) Citrobacter freundii (119899 = 1) Acinetobacterbaumanii (119899 = 3) and Enterobacter cloacae (119899 = 4) werecollected fromblood urine pus and sputum specimens fromhospitalized patients in ZagazigUniversityHospitals in Egyptfrom January 2013 toMarch 2014These clinical samples wereprocessed by plating on blood agar and MacConkey agar[9] A growth temperature of 44∘C was used sometimes toconfirm the identity of these isolates and the identified strainswere stored in glycerol (20 VV) at 70∘C and subculturedseveral times to be viable All isolates were identified bystandard biochemical tests [10] and confirmed by API 20E(BioMerieux Marcy lrsquoEtoile France)
22 Antibiotic Susceptibility Testing The susceptibility testingof studied isolates was performed by disc diffusion method(modified Kirby-Bauer method) using Muller-Hinton agar(Becton Dickinson MA USA) and interpreted accordingto the Clinical Laboratory Standard Institute (CLSI) guide-lines [11] The antibiotic disks used imipenem (IPM 10 120583g)amikacin (AK 30 120583g) ciprofloxacin (CIP 5 120583g) piperacillin(PRL 100 120583g) cefoperazonesulbactam (CES 10 + 5 120583g)cefoxitin (FOX 30 120583g) and cefotaxime (CTX 30120583g) whichwere placed 15mm away from the central disc and the plateswere incubated for about 18ndash24 hrs at 37∘C
23 Molecular Detection of 120573-Lactamase Genes by PCR Fordetection of 120573-lactamase genes responsible for imipenem-resistance rapid genomic DNA was prepared from aboutfive colonies heated in 100mL distilled water (95∘C for10min) followed by a centrifugation step of cell suspension at
12000 rpm for 5min then supernatant was taken as a sourceof template DNA PCR amplification was carried out by usingDNA thermal cycler (Biometra Singapore) using a specificprimer for 119887119897119886VIM 119887119897119886TEM 119887119897119886SHV 119887119897119886CTX-M-1 119887119897119886CTX-M-9and 119887119897119886CTX-M-825 (Table 1) in a 50120583L volume containing 10xPCR buffer 2mM deoxynucleoside triphosphates 34 pmolof each primer 25mM MgCl
2 1 U Taq DNA polymerase
and 1 120583L of genomic DNA [12] Amplification was carriedout as follows initial denaturation at 94∘C for 10 minutesfollowed by 40 cycles of DNA denaturation at 94∘C for40 seconds primer annealing at 60∘C for 40 seconds andprimer extension at 72∘C for 1 minute and a final elongationstep at 72∘C for 7 minutes The annealing temperature wasoptimal at 55∘C instead of 60∘C for amplification of 119887119897119886VIMAmplicons were then visualized after running in 2 agarosegel at 100V for 30mins A 50ndash1000 bpDNA ladder (USA)wasused as a size marker Finally PCR products were purifiedwith innuPREP PCRpure kit (Analytik Jena Germany) andsubjected to direct sequencing via GATC Company by use ofABI 3730xl DNA sequencer
24 Bioinformatics and Sequences Analysis The obtainedchromatogram sequencing files were inspected and correctedusing the software application Chromas 23 (TechnelysiumHelensvale Australia) and JalView (28)
The sequences obtained from our samples were alignedwith GenBank sequences The phylogenetic tree for eachsequence was obtained by performing neighbor-joining anal-ysis of the alignment of sequences with reference strains(accession numberscountry of origin) that were retrievedfrom GenBank The studied strains were marked by the sign[◼] Meanwhile the reference sequences were marked by thesign [998771]
The BLAST and FASTA programs of the National Centerfor Biotechnology Information (httpblastncbinlmnihgovBlastcgi) were used to search databases for similarnucleotide sequences [13] Multiple sequence alignments ofthe nucleic acidwere carried out using theClustalWprogramThe statistical analysis was performed using SPSS version
International Journal of Microbiology 3
477
615538
231323
184
015 15 46 92 610 0
508446 415
677615
815
100
SusceptibleIntermediateResistant
0102030405060708090
100
()
Imip
enem
Am
ikac
in
Cipr
oflox
acin
Pipe
raci
llin
Cef
oxiti
n
Cef
otax
ime
Cef
oper
azon
e(s
ulba
ctam
)
Figure 1 Antimicrobial susceptibility patterns of all 65 Gram-negative bacilli isolates
2001205942 = chi-square test and119875 valueslt 005were consideredsignificant
3 Results
31 Isolation and Identification The present study was con-ducted on 65 screened isolates of Gram-negative bacilliobtained from 108 various clinical samples such as urineblood pus and sputum where 41 (788) were isolatedfrom urine 12 (666) from blood 14 (482) from respi-ratory secretions and 2 (222) from pus Escherichia coli(461) was the most commonly isolated organism amongGram-negative bacilli followed by Klebsiella pneumoniae(262) Pseudomonas aeruginosa (107) Enterobacter cloa-cae (61) Proteus mirabilis (307) and Acinetobacter bau-manii (46) while Citrobacter freundii and Proteus vulgarisgave 15 The isolation of Gram-negative bacilli isolates wassignificantly higher in patients with trauma (119875 lt 0001)those hospitalized for more than 7 days (119875 lt 0001) andthose with ICU admission (119875 lt 0001) harboring risk factorsfor acquiring Gram-negative bacilli infection
32 The Antibiotic Susceptibility Testing It was shown inFigure 1 as observed that 40 (615) were susceptibleto amikacin 35 (538) were susceptible to ciprofloxacin31 (477) were susceptible to imipenem and 21 (323)were susceptible to cefoperazonesulbactam However allisolates were resistant to cefotaxime (100) 53 (815) ofisolates were resistant to cefoxitin 44 (677) were resis-tant to piperacillin 40 (615) were resistant to cefoper-azonesulbactam 33 (508) were resistant to imipenemfollowed by 24 (446) resistant to amikacin and 27 (415)were resistant to ciprofloxacin
33 PCRAssay Results As shown in Table 6 of 33 imipenem-resistant Gram-negative bacillistrains the results of PCR
amplification products of 120573-lactamases genes showed that667 of isolates carried 119887119897119886VIM at 390 bp (Figure 2(a))727 had 119887119897119886TEM at 800 bp (Figure 2(b)) 360 harbored119887119897119886CTX-M-1 at 688 bp (Figure 2(c)) and 150 showed 119887119897119886SHV(Figure 2(d)) while 182 (Figure 2(e)) 000 (Figure 2(f))harbored 119887119897119886CTX-M-9 119887119897119886CTX-M-825 respectively Sequencingconfirmed presence of these 120573-lactamase genes the GenBanknucleotide sequence accession numbers for the sequencesstudied are detailed Aligning of the obtained sequences withthose of reference strains in GenBank confirmed the correctidentification of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHV and 119887119897119886CTX-M genesby PCR
34 Sequences Analysis and Polymorphism
341 The Analysis of VIM Gene (119887119897119886VIM12) The sequence ofthe purified product of VIM gene (119887119897119886VIM12) was comparedwith homologousGenBank sequences using BLAST programand resulted in significant similarity to many metallo-120573-lactamases genes of different bacterial strains
(1) VIM Gene (blaVIM12) in Escherichia coli Strains The pair-wise sequences alignments of resulting VIM gene (119887119897119886VIM12)in E coli strains isolated from Zagazig University (ZU)Hospitals in comparison with published VIM gene in Ecoli strains from GenBank for example (E coli KC4173771)showed single common SNP (single nucleotide polymor-phism) sites between the different strains The SNPs posi-tion was indicated in position 382 in the Egyptian strains(Figure 3(a))The phylogenetic tree of VIM gene sequence inE coli strains isolated fromZagazigUniversityHospitals andpublished homologous sequences in GenBank showed dif-ferent degrees of dissimilarity between the different strains(Figure 3(b)) It was interesting to detect that both strainsthe most similar and most dissimilar strains were from thesame country Greece indicating biodiversity in the samegeographical location
(2) VIMGene (blaVIM12) in Klebsiella pneumoniae StrainsTheVIM gene isolated from K pneumoniae strains in ZagazigUniversity Hospitals was comparedwith publishedVIM genein K pneumoniae strains from GenBank (eg K pneumoniaeDQ1439131) The results showed 6 different common SNPsbetween the different strains The SNPs positions were indi-cated in 45 150 168 284 309 and 363 (Figure 3(c)) Thephylogenetic tree of VIM gene sequence in K pneumoniaestrains isolated from ZU Hospitals and published homol-ogous sequences in GenBank showed different degrees ofdissimilarity between the different strains with many uniquesequences in the Egyptian strain (Figure 3(d))
(3) VIM Gene (blaVIM12) in Acinetobacter baumanii StrainsThe sequence of purified product of VIM gene (119887119897119886VIM12)from Acinetobacter baumanii strain was compared with theGenBank sequence using BLAST program Interestingly itwas revealed that therewas a single strain present inGenBankwhich is completely different from the studied strains andthis is notmatchingwith our study (eg Staphylococcus phageStB12 complete genome) The sequence alignment showed 9
4 International Journal of Microbiology
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
390
(a)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
800
(b)1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
688
(c)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
713
(d)1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
561
(e)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
326
(f)
Figure 2 Presence and absence of 120573-lactamase genes by PCR amplification in some isolated samples (a)The existence of VIM amplificationfragment (390 bp) (b) The amplification of TEM fragments (800 bp) (c) The amplification of CTX-M-1 (688 bp) (d) The presence of SHV(713 bp) in some samples (e) The presence of CTX-M-9 (561 bp) (f) No amplification was shown with CTX-M-825 primer at 326 bp
different common SNPs between the different strains Thesepositions were indicated in 246 284 306 309 330 363 378382 and 383 (Figure 3(e)) The phylogenetic tree of VIMsequence of A baumanii isolated from ZU Hospitals andpublished ones in GenBank showed dissimilarity betweenEgyptian strains and others (Figure 3(f))
342 Sequence Analysis of TEM Gene (119887119897119886VIM12) Sequencesof the purified product of VIM gene (119887119897119886VIM12) were com-paredwith homologous counterpartGenBank database using
BLASTprogramand resulted in significant similarity tomanymetallo-120573-lactamases genes of different bacterial strains
(1) TEM Gene (blaTEM12) of Escherichia coli The TEM genesequences of E coli strains isolated from ZU Hospitalswere aligned with sequences of published TEM genes in Ecoli strains from GenBank (eg E coli KM5986651) Theresulting alignments showed 4 different common SNP sitesbetween the different strains The SNPs positions were indi-cated commonly in 216 232 385 and 433 (Figure 4(a)) Phy-logenetic tree was constructed from TEM gene (119887119897119886TEM12)
International Journal of Microbiology 5
AM_372945-22_2-group16-_Vim-group16-_H031-316gi1-390
Consensus
152227
264339
AM_372945-22_2-group16-_Vim-group16-_H031-316gi1-390
Consensus
265340
316390
(a)
AM 372945-22-2-group16-Vim-group16-H03 Ecoli Egypt0000
0000
0000
117376
117339
0037
20
KC4173771
gi Escherichia coli (blaVIM-1) EF0786971 Greece
gi Escherichia coli (blaVIM-1) GU7248711 France
gi Escherichia coli (blaVIM-2) gene KF8566171 Spaingi Escherichia coli blaVIM-1 gene AY7814131 Greece
(b)1111111111
121121121121121121121121121121
361361361361361361361361361361
241241241241241241241241241241
120120120120120120120120120120
240240240240240240240240240240
390390390390390390390390390390
360360360360360360360360360360
Consensus
Consensus
Consensus
Consensus
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
(c)
gi Klebsiella pneumoniae VIM-2 genes |DQ1532171| Koreagi| Klebsiella pneumoniae strain (VIM-1) |GQ4228371| USA
gi Klebsiella pneumoniae plasmid|NG 0362531| USAAM 372945-24 4-group16-Vim-group16-H03 Kpneumonia Egypt
000
0011
00040002
000900090009
DQ1439131
0008 0006 0004 0002 00000010Relative times
gi Klebsiella pneumoniae strain (blaVIM-1) |GQ4228271| USA
(d)
Figure 3 Continued
6 International Journal of Microbiology
168168184168168243243
289289305289289364364
288288304288288363363
317315331315315390390
Consensus
Consensus
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
(e)
gi Acinetobacter baumannii VIM-1 |EF6906951| Greece
AM 372945-23 3-group16-Vim-group16-G03 Abaumanii Egypt0556
0009
0000
00000011
0542
0006
01
JN7005202
gi A baumannii class I integron (blaVIM-1) |EF6906961| Greece
gi Acinetobacter baumannii strain VIM (blaVIM) |JF7029211| India
gi Acinetobacter baumannii strain (blaVIM) |JF7029191| India
(f)
Figure 3Themultiple sequences alignments and trees of VIM gene in different species (a) VIM gene in E coli strains isolated from ZagazigUniversity (ZU) Hospitals in comparison with published VIM gene of E coli strains from GenBank (b) A tree of VIM sequence of E coliisolated from ZU Hospitals and published homologs in GenBank (c) The multiple sequences alignments of VIM gene in K pneumoniaestrains isolated from ZUHospitals in comparison with published VIM gene inK pneumoniae strains fromGenBank (d) Phylogenetic tree ofVIM sequence of K pneumoniae isolated from ZUHospitals and published sequences in GenBank (e)Themultiple sequences alignments ofVIM gene in A baumanii strains isolated from ZUHospitals in comparison with published VIM gene in A baumanii strains from GenBank(f) Phylogenetic tree of VIM sequence of A baumanii isolated from ZU Hospitals and published sequences in GenBank
sequence of Escherichia coli strains isolated from ZU Hos-pitals and published homologous sequences in GenBank(Figure 4(b)) showing similarity degree between Egyptianand Indian strains
(2) TEM Gene (blaTEM12) of Klebsiella pneumonia Multiplesequences alignments of TEM gene inK pneumoniae strainsisolated from ZU Hospitals were compared with other pub-lished TEM genes in K pneumoniae strains from GenBank(eg K pneumoniae KF2683571) (Figure 4(c)) showed 2different common SNPs between different strains The SNPspositions were indicated in 174 and 343 A phylogenetictree of TEM sequence of K pneumoniae isolated fromZagazig University Hospitals and other published ones inGenBank showed the degree of similarity between strainswhere Egyptian strain was dissimilar to that of Iranian andIndian strains (Figure 4(d))
343 The Analysis of SHV Gene (119887119897119886SHV1) in Klebsiellapneumoniae Strains The pairwise sequences alignments ofresulting SHV gene (119887119897119886SHV1) in K pneumoniae strains iso-lated from Zagazig University Hospitals in comparison withpublished SHV gene inK pneumoniae strains fromGenBankusing BLAST program (eg K pneumoniae AF1249841)
showed five common SNPs between the different strainsTheSNPs position was indicated in 454 563 631 635 and 650in Egyptian strains (Figure 5(a)) The phylogenetic tree ofSHV gene in this case showed that Egyptian strain was moresimilar to France strain (Figure 5(b))
344The Analysis of CTX-M-1 Gene (119887119897119886CTX-M-1) Sequencesof the purified product of CTX-M-1 gene (119887119897119886CTX-M-1) werecompared with homologous counterpart GenBank databaseusing BLAST program and resulted in significant similarityto many metallo-120573-lactamases genes of different bacterialstrains
(1) CTX-M-1 Gene (blaCTX-M-1) of Escherichia coli Strains Thesequence of the purified product of CTX-M-1 gene fromEscherichia coli strains was compared with the GenBanksequence using BLASTprogram Interestingly it was revealedthat there were strains present in GenBank which are com-pletely different from the studied strains and this is notmatchingwith our study (egPseudomonas aeruginosaDNAAP0146461) The sequence alignment showed 81 differentcommon SNPs between the different strains The SNPspositions were indicated in 601 604rarr 615 617rarr 626 and628rarr 688 (Figure 6(a)) The phylogenetic tree of CTX-M-1
International Journal of Microbiology 7
91115115115
205229229229
319343343343
433457457457
547571571571
204228228228
318342342342
432456456456
546570570570
660684684684
Consensus
Consensus
Consensus
Consensus
Consensus
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
(a)
TEM Ecoli Egypt
00041
0002700000
00014
00005
KM5986651gi|675594620|gb|KJ9230021| Escherichia coli strain blaTEM (blaTEM-1) India
gi|383282208|gb|JQ8231751| Escherichia beta-lactamase TEM (blaTEM) India
gi|347810716|gb|JN1883651| Escherichia coli strain ARY 4 blaTEM gene India
(b)115102111111111111111
229216225225225225225
343330339339339339339
228215224224
342329338338338338338
456443452452452452452
224224224
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
Consensus
Consensus
Consensus
(c)
AM 372945-26 6-group16-T-group16-B04 Kpneumonia Egypt00022
00033
00000
00000
00000
00000
00000
0001500004
00015
00005
00005
KF2683571gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346951| Iran
gi Klebsiella pneumoniae beta-lactamase TEM-1 (blaTem) |GQ4704601| Irangi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |GU7346961| Iran
gi Klebsiella pneumoniae strain TEM-1 (blaTem) gene |GU7346941| Iran
gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346901| Iran
gi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |JN0433841| India
(d)
Figure 4 The multiple sequences alignments and trees of TEM gene (119887119897119886TEM12) in different bacterial species (a) TEM gene in E coli strainsisolated fromZUHospitals in comparisonwith publishedTEMgene ofE coli strains fromGenBank (b)Aphylogenetic tree of TEMgene ofEcoli isolated fromZUHospitals and published homologous ones inGenBank (c)Themultiple sequences alignments of gene inK pneumoniaestrains isolated from ZU Hospitals in comparison with published TEM gene in K pneumoniae strains from GenBank (d) Phylogenetic treeof sequence of K pneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
8 International Journal of Microbiology
340
340340340340
340340
453
453453453453
453453
566
566566566566
566566
324
324324
211
211211
98
9898
452
452452452452
452452
210
210210
565
565565565
565565
565
323
323323
678
678678678678
678678
436
436436
Consensus
Consensus
Consensus
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
(a)
gi Klebsiella pneumoniae conjugative plasmid beta-lactamase SHV-13 (bla) gene |AF1645771| UK
AM_372945-30 13-group16-T-group16-A04 Ecloacae Egypt
gi Klebsiella pneumoniae beta-lactamase SHV-14 (bla) gene |AF2266221| UK
00000
00022
00087
00022
00000
00000
000000004300000
0002200022
00022
00022
00000
0001
AF1249841
gi Klebsiella pneumoniae extended spectrum beta-lactamase SHV-1 (blaSHV) gene |HM0605401| Iran
gi Klebsiella pneumoniae strain K16R SHV-1 beta-lactamase (blaSHV) gene |HM7511021| Brazil
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-11 (blaSHV) |GQ4704281| Iran
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-1 (blaSHV) |HM0605381| Iran
gi Klebsiella pneumoniae plasmid blaSHV gene for beta-lactamase SHV |AB6757231| Japan
gi Klebsiella pneumoniae blaSHV type 1 gene complete cds|DQ3557841| Brazil
gi Klebsiella pneumoniae blaSHV gene for beta-lactamase class A |Y110691| France
(b)
Figure 5Themultiple sequences alignments and trees of SHV gene in different species (a) SHV gene inK pneumoniae strains isolated fromZUHospitals in comparison with published SHV gene of K pneumoniae strains from GenBank (b) Phylogenetic tree of SHV sequence of Kpneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
sequence of E coli isolated fromZagazig University Hospitalsand published homologous ones in GenBank showed dissim-ilarity degree between Egyptian and other universal strains(Figure 6(b))
(2) CTX-M-1 Gene (blaCTX-M-1) of Klebsiella pneumoniaeStrains The alignment in this case showed 39 differentcommon SNPs between the different strains The SNPspositions were indicated in positions 1 rarr 39 (Figure 6(c))A phylogenetic tree of CTX-M-1 gene sequence in K pneu-moniae strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed different degrees
of dissimilarity between the different strains with manyunique sequences in Egyptian strain (Figure 6(d))
(3) CTX-M-1 Gene (blaCTX-M-1) of Pseudomonas aeruginosaStrainsTheCTX-M-1 gene isolated fromP aeruginosa strainsin Zagazig University Hospitals was compared using BLASTprogram with published CTX-M-1 gene in P aeruginosastrains from GenBank (eg Paeruginosa KC5712551) Theresults showed 4 different common SNPs between the differ-ent strainsThe SNPs positions were indicated in 117 206 228and 283 (Figure 6(e)) A phylogenetic tree showed similaritydegree between Egyptian and Russian strains (Figure 6(f))
International Journal of Microbiology 9
601601601601
629688688688
Consensus
CTX11-629gi|695214033|ref|NG_0367291|1-688gi|224696954|emb|FM2133711|1-688gi|402795953|dbj|AB7015731|1-688
(a)
CTX1 Ecoli Egypt05168
00000
00000
0000005168
01
AP0146461
gi |NG 0367291| Escherichia coli blaCTX-M-3 gene for beta-lactamase USA
gi Escherichia coli DNA ISEcp1-blaCTX-M-15 |AB7015731| Japan
gi Escherichia coli blaCTX-M-3 gene for beta-lactamase |FM2133711| Poland
(b)227
2911
340142
3391417474
452254187187
7575
Consensus
Consensus
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
(c)
gi Klebsiella pneumoniae strain 285L extended spectrum beta-lactamase CTX-M-15 |GQ4704351|Iran
CTX1 Klebsiella pneumoniae Egyptgi Klebsiella pneumoniae strain 212L extended spectrum beta-lactamase CTX-M-15 |GQ4704311| Irangi Klebsiella pneumoniae CTX-M-15|GQ8655681| India
00000
0000000000
07585
07515
00070
02
KJ4514101
gi Klebsiella pneumoniae (blaCTX-M-15) gene |EU5567551|Hungary
(d)56
113113
167224224
279336336
391448448
168225225
280337337
Consensus
Consensus
Consensus
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
(e)
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia(2)CTX1 Pseudomonas aeruginosa Egypt00024
00000
0000000024
00005
KC5712551
(f)
Figure 6 The multiple sequences alignments and trees of CTX-M-1 gene in different species (a) CTX-M-1 gene in E coli strains isolatedfrom ZU Hospitals in comparison with published CTX-M-1 gene of E coli strains from GenBank (b) A tree of CTX-M-1 sequence of E coliisolated from ZUHospitals and published homologs in GenBank (c)Themultiple sequences alignments of CTX-M-1 gene in K pneumoniaestrains isolated from ZU Hospitals in comparison with published CTX-M-1 gene in K pneumoniae strains from GenBank (d) Phylogenetictree of CTX-M-1 sequence of K pneumoniae isolated from ZU Hospitals and published homologous sequences in GenBank (e) Multiplesequences alignments of CTX-M-1 gene in P aeruginosa strains isolated from ZU Hospitals in comparison with published CTX-M-1 gene inP aeruginosa strains from GenBank (f) Phylogenetic tree of CTX-M-1 sequence of P aeruginosa isolated from ZU Hospitals and publishedhomologs in GenBank
10 International Journal of Microbiology
11111
113113113113113
225225225225225
Consensus
Consensus
Consensus
112112112112112
224224224224224
336336336336336
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
(a)
00000
00000
00037
00037
00005
JN6768431
AM 372945-35 21-group16- g9-group16- C05 (830bp) Ecoli Egypt
gi Escherichia coli (blaCTX-M-9b) gene complete cds |EU4189151|Australia
gi Escherichia coli strain K-340 (blaCTX-M-9) gene complete cds |HM5697351|Russia
gi Escherichia coli DNA blaCTX-M-14 gene |AB9765961|Japan
(b)
Figure 7Themultiple sequences alignments and tree of CTX-M-9 gene in different species (a) CTX-M-9 gene in E coli strains isolated fromZU Hospitals in comparison with published CTX-M-9 gene of E coli strains from GenBank (b) Phylogenetic tree of CTX-M-9 sequence ofE coli isolated from ZU Hospitals and published homologous ones in GenBank
345 The Analysis of CTX-M-9 Gene (119887119897119886CTX-M-9) inEscherichia coli Strains The CTX-M-9 gene isolated fromE coli strains in Zagazig University Hospitals was comparedwith published CTX-M-1 gene in P aeruginosa strains fromGenBank using BLAST program (eg E coli JN6768431)The multiple sequences alignments showed 2 differentcommon SNPs in positions 74 and 272 (Figure 7(a))The phylogenetic tree of CTX-M-9 gene sequence in Ecoli strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed differentdegrees of dissimilarity between the different strains andmany unique sequences in the Egyptian strain similar tothat of Russia and Australia and dissimilar to that of Japan(Figure 7(b))
4 Discussion
The Gram-negative bacilli are among the most importantcauses of serious nosocomial and community-onset bacte-rial infections in humans and antimicrobial resistance hasbecome a global threat to effective health care delivery [14]However carbapenem-resistant Gram-negative bacilli havebeen increasingly reported worldwide [4] Various acquiredcarbapenemases have been identified in the last years belong-ing to either acquired metallo-beta-lactamases (IMP VIM
Table 2 The distribution of Gram-negative bacilli isolates in eachclinical specimen
Clinical specimens Gram-negative bacilli isolatesType Number Number ()Urine 52 41 788Blood 18 12 666Sputum 29 10 345Pus 9 2 222Total 108 65 (602)1205942= 2128 119875 lt 0001 (statistically significant)
SPM GIM NDM andDIM types) or class A (KPC andGES)and class D 120573-lactamase OXA-48 [15]
In the present study prevalence of 120573-lactamases-producing isolates was found in Table 2 Different studiescarried out by other workers in various parts of the worldshow quite variable results In a study carried out thefrequency of beta-lactamases-producing isolates was urine(61) followed by blood cultures (38) wound swabs (13)and tracheal aspirates (5) (119875 lt 0001) [16] And this issimilar to our study By contrast Shanthi and Sekar [17] inIndia reported that Gram-negative isolates were obtainedfrom the respiratory tract (418) followed by urinary tract
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
International Journal of Microbiology 3
477
615538
231323
184
015 15 46 92 610 0
508446 415
677615
815
100
SusceptibleIntermediateResistant
0102030405060708090
100
()
Imip
enem
Am
ikac
in
Cipr
oflox
acin
Pipe
raci
llin
Cef
oxiti
n
Cef
otax
ime
Cef
oper
azon
e(s
ulba
ctam
)
Figure 1 Antimicrobial susceptibility patterns of all 65 Gram-negative bacilli isolates
2001205942 = chi-square test and119875 valueslt 005were consideredsignificant
3 Results
31 Isolation and Identification The present study was con-ducted on 65 screened isolates of Gram-negative bacilliobtained from 108 various clinical samples such as urineblood pus and sputum where 41 (788) were isolatedfrom urine 12 (666) from blood 14 (482) from respi-ratory secretions and 2 (222) from pus Escherichia coli(461) was the most commonly isolated organism amongGram-negative bacilli followed by Klebsiella pneumoniae(262) Pseudomonas aeruginosa (107) Enterobacter cloa-cae (61) Proteus mirabilis (307) and Acinetobacter bau-manii (46) while Citrobacter freundii and Proteus vulgarisgave 15 The isolation of Gram-negative bacilli isolates wassignificantly higher in patients with trauma (119875 lt 0001)those hospitalized for more than 7 days (119875 lt 0001) andthose with ICU admission (119875 lt 0001) harboring risk factorsfor acquiring Gram-negative bacilli infection
32 The Antibiotic Susceptibility Testing It was shown inFigure 1 as observed that 40 (615) were susceptibleto amikacin 35 (538) were susceptible to ciprofloxacin31 (477) were susceptible to imipenem and 21 (323)were susceptible to cefoperazonesulbactam However allisolates were resistant to cefotaxime (100) 53 (815) ofisolates were resistant to cefoxitin 44 (677) were resis-tant to piperacillin 40 (615) were resistant to cefoper-azonesulbactam 33 (508) were resistant to imipenemfollowed by 24 (446) resistant to amikacin and 27 (415)were resistant to ciprofloxacin
33 PCRAssay Results As shown in Table 6 of 33 imipenem-resistant Gram-negative bacillistrains the results of PCR
amplification products of 120573-lactamases genes showed that667 of isolates carried 119887119897119886VIM at 390 bp (Figure 2(a))727 had 119887119897119886TEM at 800 bp (Figure 2(b)) 360 harbored119887119897119886CTX-M-1 at 688 bp (Figure 2(c)) and 150 showed 119887119897119886SHV(Figure 2(d)) while 182 (Figure 2(e)) 000 (Figure 2(f))harbored 119887119897119886CTX-M-9 119887119897119886CTX-M-825 respectively Sequencingconfirmed presence of these 120573-lactamase genes the GenBanknucleotide sequence accession numbers for the sequencesstudied are detailed Aligning of the obtained sequences withthose of reference strains in GenBank confirmed the correctidentification of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHV and 119887119897119886CTX-M genesby PCR
34 Sequences Analysis and Polymorphism
341 The Analysis of VIM Gene (119887119897119886VIM12) The sequence ofthe purified product of VIM gene (119887119897119886VIM12) was comparedwith homologousGenBank sequences using BLAST programand resulted in significant similarity to many metallo-120573-lactamases genes of different bacterial strains
(1) VIM Gene (blaVIM12) in Escherichia coli Strains The pair-wise sequences alignments of resulting VIM gene (119887119897119886VIM12)in E coli strains isolated from Zagazig University (ZU)Hospitals in comparison with published VIM gene in Ecoli strains from GenBank for example (E coli KC4173771)showed single common SNP (single nucleotide polymor-phism) sites between the different strains The SNPs posi-tion was indicated in position 382 in the Egyptian strains(Figure 3(a))The phylogenetic tree of VIM gene sequence inE coli strains isolated fromZagazigUniversityHospitals andpublished homologous sequences in GenBank showed dif-ferent degrees of dissimilarity between the different strains(Figure 3(b)) It was interesting to detect that both strainsthe most similar and most dissimilar strains were from thesame country Greece indicating biodiversity in the samegeographical location
(2) VIMGene (blaVIM12) in Klebsiella pneumoniae StrainsTheVIM gene isolated from K pneumoniae strains in ZagazigUniversity Hospitals was comparedwith publishedVIM genein K pneumoniae strains from GenBank (eg K pneumoniaeDQ1439131) The results showed 6 different common SNPsbetween the different strains The SNPs positions were indi-cated in 45 150 168 284 309 and 363 (Figure 3(c)) Thephylogenetic tree of VIM gene sequence in K pneumoniaestrains isolated from ZU Hospitals and published homol-ogous sequences in GenBank showed different degrees ofdissimilarity between the different strains with many uniquesequences in the Egyptian strain (Figure 3(d))
(3) VIM Gene (blaVIM12) in Acinetobacter baumanii StrainsThe sequence of purified product of VIM gene (119887119897119886VIM12)from Acinetobacter baumanii strain was compared with theGenBank sequence using BLAST program Interestingly itwas revealed that therewas a single strain present inGenBankwhich is completely different from the studied strains andthis is notmatchingwith our study (eg Staphylococcus phageStB12 complete genome) The sequence alignment showed 9
4 International Journal of Microbiology
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
390
(a)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
800
(b)1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
688
(c)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
713
(d)1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
561
(e)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
326
(f)
Figure 2 Presence and absence of 120573-lactamase genes by PCR amplification in some isolated samples (a)The existence of VIM amplificationfragment (390 bp) (b) The amplification of TEM fragments (800 bp) (c) The amplification of CTX-M-1 (688 bp) (d) The presence of SHV(713 bp) in some samples (e) The presence of CTX-M-9 (561 bp) (f) No amplification was shown with CTX-M-825 primer at 326 bp
different common SNPs between the different strains Thesepositions were indicated in 246 284 306 309 330 363 378382 and 383 (Figure 3(e)) The phylogenetic tree of VIMsequence of A baumanii isolated from ZU Hospitals andpublished ones in GenBank showed dissimilarity betweenEgyptian strains and others (Figure 3(f))
342 Sequence Analysis of TEM Gene (119887119897119886VIM12) Sequencesof the purified product of VIM gene (119887119897119886VIM12) were com-paredwith homologous counterpartGenBank database using
BLASTprogramand resulted in significant similarity tomanymetallo-120573-lactamases genes of different bacterial strains
(1) TEM Gene (blaTEM12) of Escherichia coli The TEM genesequences of E coli strains isolated from ZU Hospitalswere aligned with sequences of published TEM genes in Ecoli strains from GenBank (eg E coli KM5986651) Theresulting alignments showed 4 different common SNP sitesbetween the different strains The SNPs positions were indi-cated commonly in 216 232 385 and 433 (Figure 4(a)) Phy-logenetic tree was constructed from TEM gene (119887119897119886TEM12)
International Journal of Microbiology 5
AM_372945-22_2-group16-_Vim-group16-_H031-316gi1-390
Consensus
152227
264339
AM_372945-22_2-group16-_Vim-group16-_H031-316gi1-390
Consensus
265340
316390
(a)
AM 372945-22-2-group16-Vim-group16-H03 Ecoli Egypt0000
0000
0000
117376
117339
0037
20
KC4173771
gi Escherichia coli (blaVIM-1) EF0786971 Greece
gi Escherichia coli (blaVIM-1) GU7248711 France
gi Escherichia coli (blaVIM-2) gene KF8566171 Spaingi Escherichia coli blaVIM-1 gene AY7814131 Greece
(b)1111111111
121121121121121121121121121121
361361361361361361361361361361
241241241241241241241241241241
120120120120120120120120120120
240240240240240240240240240240
390390390390390390390390390390
360360360360360360360360360360
Consensus
Consensus
Consensus
Consensus
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
(c)
gi Klebsiella pneumoniae VIM-2 genes |DQ1532171| Koreagi| Klebsiella pneumoniae strain (VIM-1) |GQ4228371| USA
gi Klebsiella pneumoniae plasmid|NG 0362531| USAAM 372945-24 4-group16-Vim-group16-H03 Kpneumonia Egypt
000
0011
00040002
000900090009
DQ1439131
0008 0006 0004 0002 00000010Relative times
gi Klebsiella pneumoniae strain (blaVIM-1) |GQ4228271| USA
(d)
Figure 3 Continued
6 International Journal of Microbiology
168168184168168243243
289289305289289364364
288288304288288363363
317315331315315390390
Consensus
Consensus
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
(e)
gi Acinetobacter baumannii VIM-1 |EF6906951| Greece
AM 372945-23 3-group16-Vim-group16-G03 Abaumanii Egypt0556
0009
0000
00000011
0542
0006
01
JN7005202
gi A baumannii class I integron (blaVIM-1) |EF6906961| Greece
gi Acinetobacter baumannii strain VIM (blaVIM) |JF7029211| India
gi Acinetobacter baumannii strain (blaVIM) |JF7029191| India
(f)
Figure 3Themultiple sequences alignments and trees of VIM gene in different species (a) VIM gene in E coli strains isolated from ZagazigUniversity (ZU) Hospitals in comparison with published VIM gene of E coli strains from GenBank (b) A tree of VIM sequence of E coliisolated from ZU Hospitals and published homologs in GenBank (c) The multiple sequences alignments of VIM gene in K pneumoniaestrains isolated from ZUHospitals in comparison with published VIM gene inK pneumoniae strains fromGenBank (d) Phylogenetic tree ofVIM sequence of K pneumoniae isolated from ZUHospitals and published sequences in GenBank (e)Themultiple sequences alignments ofVIM gene in A baumanii strains isolated from ZUHospitals in comparison with published VIM gene in A baumanii strains from GenBank(f) Phylogenetic tree of VIM sequence of A baumanii isolated from ZU Hospitals and published sequences in GenBank
sequence of Escherichia coli strains isolated from ZU Hos-pitals and published homologous sequences in GenBank(Figure 4(b)) showing similarity degree between Egyptianand Indian strains
(2) TEM Gene (blaTEM12) of Klebsiella pneumonia Multiplesequences alignments of TEM gene inK pneumoniae strainsisolated from ZU Hospitals were compared with other pub-lished TEM genes in K pneumoniae strains from GenBank(eg K pneumoniae KF2683571) (Figure 4(c)) showed 2different common SNPs between different strains The SNPspositions were indicated in 174 and 343 A phylogenetictree of TEM sequence of K pneumoniae isolated fromZagazig University Hospitals and other published ones inGenBank showed the degree of similarity between strainswhere Egyptian strain was dissimilar to that of Iranian andIndian strains (Figure 4(d))
343 The Analysis of SHV Gene (119887119897119886SHV1) in Klebsiellapneumoniae Strains The pairwise sequences alignments ofresulting SHV gene (119887119897119886SHV1) in K pneumoniae strains iso-lated from Zagazig University Hospitals in comparison withpublished SHV gene inK pneumoniae strains fromGenBankusing BLAST program (eg K pneumoniae AF1249841)
showed five common SNPs between the different strainsTheSNPs position was indicated in 454 563 631 635 and 650in Egyptian strains (Figure 5(a)) The phylogenetic tree ofSHV gene in this case showed that Egyptian strain was moresimilar to France strain (Figure 5(b))
344The Analysis of CTX-M-1 Gene (119887119897119886CTX-M-1) Sequencesof the purified product of CTX-M-1 gene (119887119897119886CTX-M-1) werecompared with homologous counterpart GenBank databaseusing BLAST program and resulted in significant similarityto many metallo-120573-lactamases genes of different bacterialstrains
(1) CTX-M-1 Gene (blaCTX-M-1) of Escherichia coli Strains Thesequence of the purified product of CTX-M-1 gene fromEscherichia coli strains was compared with the GenBanksequence using BLASTprogram Interestingly it was revealedthat there were strains present in GenBank which are com-pletely different from the studied strains and this is notmatchingwith our study (egPseudomonas aeruginosaDNAAP0146461) The sequence alignment showed 81 differentcommon SNPs between the different strains The SNPspositions were indicated in 601 604rarr 615 617rarr 626 and628rarr 688 (Figure 6(a)) The phylogenetic tree of CTX-M-1
International Journal of Microbiology 7
91115115115
205229229229
319343343343
433457457457
547571571571
204228228228
318342342342
432456456456
546570570570
660684684684
Consensus
Consensus
Consensus
Consensus
Consensus
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
(a)
TEM Ecoli Egypt
00041
0002700000
00014
00005
KM5986651gi|675594620|gb|KJ9230021| Escherichia coli strain blaTEM (blaTEM-1) India
gi|383282208|gb|JQ8231751| Escherichia beta-lactamase TEM (blaTEM) India
gi|347810716|gb|JN1883651| Escherichia coli strain ARY 4 blaTEM gene India
(b)115102111111111111111
229216225225225225225
343330339339339339339
228215224224
342329338338338338338
456443452452452452452
224224224
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
Consensus
Consensus
Consensus
(c)
AM 372945-26 6-group16-T-group16-B04 Kpneumonia Egypt00022
00033
00000
00000
00000
00000
00000
0001500004
00015
00005
00005
KF2683571gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346951| Iran
gi Klebsiella pneumoniae beta-lactamase TEM-1 (blaTem) |GQ4704601| Irangi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |GU7346961| Iran
gi Klebsiella pneumoniae strain TEM-1 (blaTem) gene |GU7346941| Iran
gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346901| Iran
gi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |JN0433841| India
(d)
Figure 4 The multiple sequences alignments and trees of TEM gene (119887119897119886TEM12) in different bacterial species (a) TEM gene in E coli strainsisolated fromZUHospitals in comparisonwith publishedTEMgene ofE coli strains fromGenBank (b)Aphylogenetic tree of TEMgene ofEcoli isolated fromZUHospitals and published homologous ones inGenBank (c)Themultiple sequences alignments of gene inK pneumoniaestrains isolated from ZU Hospitals in comparison with published TEM gene in K pneumoniae strains from GenBank (d) Phylogenetic treeof sequence of K pneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
8 International Journal of Microbiology
340
340340340340
340340
453
453453453453
453453
566
566566566566
566566
324
324324
211
211211
98
9898
452
452452452452
452452
210
210210
565
565565565
565565
565
323
323323
678
678678678678
678678
436
436436
Consensus
Consensus
Consensus
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
(a)
gi Klebsiella pneumoniae conjugative plasmid beta-lactamase SHV-13 (bla) gene |AF1645771| UK
AM_372945-30 13-group16-T-group16-A04 Ecloacae Egypt
gi Klebsiella pneumoniae beta-lactamase SHV-14 (bla) gene |AF2266221| UK
00000
00022
00087
00022
00000
00000
000000004300000
0002200022
00022
00022
00000
0001
AF1249841
gi Klebsiella pneumoniae extended spectrum beta-lactamase SHV-1 (blaSHV) gene |HM0605401| Iran
gi Klebsiella pneumoniae strain K16R SHV-1 beta-lactamase (blaSHV) gene |HM7511021| Brazil
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-11 (blaSHV) |GQ4704281| Iran
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-1 (blaSHV) |HM0605381| Iran
gi Klebsiella pneumoniae plasmid blaSHV gene for beta-lactamase SHV |AB6757231| Japan
gi Klebsiella pneumoniae blaSHV type 1 gene complete cds|DQ3557841| Brazil
gi Klebsiella pneumoniae blaSHV gene for beta-lactamase class A |Y110691| France
(b)
Figure 5Themultiple sequences alignments and trees of SHV gene in different species (a) SHV gene inK pneumoniae strains isolated fromZUHospitals in comparison with published SHV gene of K pneumoniae strains from GenBank (b) Phylogenetic tree of SHV sequence of Kpneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
sequence of E coli isolated fromZagazig University Hospitalsand published homologous ones in GenBank showed dissim-ilarity degree between Egyptian and other universal strains(Figure 6(b))
(2) CTX-M-1 Gene (blaCTX-M-1) of Klebsiella pneumoniaeStrains The alignment in this case showed 39 differentcommon SNPs between the different strains The SNPspositions were indicated in positions 1 rarr 39 (Figure 6(c))A phylogenetic tree of CTX-M-1 gene sequence in K pneu-moniae strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed different degrees
of dissimilarity between the different strains with manyunique sequences in Egyptian strain (Figure 6(d))
(3) CTX-M-1 Gene (blaCTX-M-1) of Pseudomonas aeruginosaStrainsTheCTX-M-1 gene isolated fromP aeruginosa strainsin Zagazig University Hospitals was compared using BLASTprogram with published CTX-M-1 gene in P aeruginosastrains from GenBank (eg Paeruginosa KC5712551) Theresults showed 4 different common SNPs between the differ-ent strainsThe SNPs positions were indicated in 117 206 228and 283 (Figure 6(e)) A phylogenetic tree showed similaritydegree between Egyptian and Russian strains (Figure 6(f))
International Journal of Microbiology 9
601601601601
629688688688
Consensus
CTX11-629gi|695214033|ref|NG_0367291|1-688gi|224696954|emb|FM2133711|1-688gi|402795953|dbj|AB7015731|1-688
(a)
CTX1 Ecoli Egypt05168
00000
00000
0000005168
01
AP0146461
gi |NG 0367291| Escherichia coli blaCTX-M-3 gene for beta-lactamase USA
gi Escherichia coli DNA ISEcp1-blaCTX-M-15 |AB7015731| Japan
gi Escherichia coli blaCTX-M-3 gene for beta-lactamase |FM2133711| Poland
(b)227
2911
340142
3391417474
452254187187
7575
Consensus
Consensus
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
(c)
gi Klebsiella pneumoniae strain 285L extended spectrum beta-lactamase CTX-M-15 |GQ4704351|Iran
CTX1 Klebsiella pneumoniae Egyptgi Klebsiella pneumoniae strain 212L extended spectrum beta-lactamase CTX-M-15 |GQ4704311| Irangi Klebsiella pneumoniae CTX-M-15|GQ8655681| India
00000
0000000000
07585
07515
00070
02
KJ4514101
gi Klebsiella pneumoniae (blaCTX-M-15) gene |EU5567551|Hungary
(d)56
113113
167224224
279336336
391448448
168225225
280337337
Consensus
Consensus
Consensus
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
(e)
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia(2)CTX1 Pseudomonas aeruginosa Egypt00024
00000
0000000024
00005
KC5712551
(f)
Figure 6 The multiple sequences alignments and trees of CTX-M-1 gene in different species (a) CTX-M-1 gene in E coli strains isolatedfrom ZU Hospitals in comparison with published CTX-M-1 gene of E coli strains from GenBank (b) A tree of CTX-M-1 sequence of E coliisolated from ZUHospitals and published homologs in GenBank (c)Themultiple sequences alignments of CTX-M-1 gene in K pneumoniaestrains isolated from ZU Hospitals in comparison with published CTX-M-1 gene in K pneumoniae strains from GenBank (d) Phylogenetictree of CTX-M-1 sequence of K pneumoniae isolated from ZU Hospitals and published homologous sequences in GenBank (e) Multiplesequences alignments of CTX-M-1 gene in P aeruginosa strains isolated from ZU Hospitals in comparison with published CTX-M-1 gene inP aeruginosa strains from GenBank (f) Phylogenetic tree of CTX-M-1 sequence of P aeruginosa isolated from ZU Hospitals and publishedhomologs in GenBank
10 International Journal of Microbiology
11111
113113113113113
225225225225225
Consensus
Consensus
Consensus
112112112112112
224224224224224
336336336336336
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
(a)
00000
00000
00037
00037
00005
JN6768431
AM 372945-35 21-group16- g9-group16- C05 (830bp) Ecoli Egypt
gi Escherichia coli (blaCTX-M-9b) gene complete cds |EU4189151|Australia
gi Escherichia coli strain K-340 (blaCTX-M-9) gene complete cds |HM5697351|Russia
gi Escherichia coli DNA blaCTX-M-14 gene |AB9765961|Japan
(b)
Figure 7Themultiple sequences alignments and tree of CTX-M-9 gene in different species (a) CTX-M-9 gene in E coli strains isolated fromZU Hospitals in comparison with published CTX-M-9 gene of E coli strains from GenBank (b) Phylogenetic tree of CTX-M-9 sequence ofE coli isolated from ZU Hospitals and published homologous ones in GenBank
345 The Analysis of CTX-M-9 Gene (119887119897119886CTX-M-9) inEscherichia coli Strains The CTX-M-9 gene isolated fromE coli strains in Zagazig University Hospitals was comparedwith published CTX-M-1 gene in P aeruginosa strains fromGenBank using BLAST program (eg E coli JN6768431)The multiple sequences alignments showed 2 differentcommon SNPs in positions 74 and 272 (Figure 7(a))The phylogenetic tree of CTX-M-9 gene sequence in Ecoli strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed differentdegrees of dissimilarity between the different strains andmany unique sequences in the Egyptian strain similar tothat of Russia and Australia and dissimilar to that of Japan(Figure 7(b))
4 Discussion
The Gram-negative bacilli are among the most importantcauses of serious nosocomial and community-onset bacte-rial infections in humans and antimicrobial resistance hasbecome a global threat to effective health care delivery [14]However carbapenem-resistant Gram-negative bacilli havebeen increasingly reported worldwide [4] Various acquiredcarbapenemases have been identified in the last years belong-ing to either acquired metallo-beta-lactamases (IMP VIM
Table 2 The distribution of Gram-negative bacilli isolates in eachclinical specimen
Clinical specimens Gram-negative bacilli isolatesType Number Number ()Urine 52 41 788Blood 18 12 666Sputum 29 10 345Pus 9 2 222Total 108 65 (602)1205942= 2128 119875 lt 0001 (statistically significant)
SPM GIM NDM andDIM types) or class A (KPC andGES)and class D 120573-lactamase OXA-48 [15]
In the present study prevalence of 120573-lactamases-producing isolates was found in Table 2 Different studiescarried out by other workers in various parts of the worldshow quite variable results In a study carried out thefrequency of beta-lactamases-producing isolates was urine(61) followed by blood cultures (38) wound swabs (13)and tracheal aspirates (5) (119875 lt 0001) [16] And this issimilar to our study By contrast Shanthi and Sekar [17] inIndia reported that Gram-negative isolates were obtainedfrom the respiratory tract (418) followed by urinary tract
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
4 International Journal of Microbiology
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
390
(a)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
800
(b)1 2 3 4 5 6 7 8 9 10
(bp)
1000900800
700
600
500
400
300
200
100
50
688
(c)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
713
(d)1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
561
(e)
1 2 3 4 5 6 7 8 9 10
(bp)
1000900800700
600
500
400
300
200
100
50
326
(f)
Figure 2 Presence and absence of 120573-lactamase genes by PCR amplification in some isolated samples (a)The existence of VIM amplificationfragment (390 bp) (b) The amplification of TEM fragments (800 bp) (c) The amplification of CTX-M-1 (688 bp) (d) The presence of SHV(713 bp) in some samples (e) The presence of CTX-M-9 (561 bp) (f) No amplification was shown with CTX-M-825 primer at 326 bp
different common SNPs between the different strains Thesepositions were indicated in 246 284 306 309 330 363 378382 and 383 (Figure 3(e)) The phylogenetic tree of VIMsequence of A baumanii isolated from ZU Hospitals andpublished ones in GenBank showed dissimilarity betweenEgyptian strains and others (Figure 3(f))
342 Sequence Analysis of TEM Gene (119887119897119886VIM12) Sequencesof the purified product of VIM gene (119887119897119886VIM12) were com-paredwith homologous counterpartGenBank database using
BLASTprogramand resulted in significant similarity tomanymetallo-120573-lactamases genes of different bacterial strains
(1) TEM Gene (blaTEM12) of Escherichia coli The TEM genesequences of E coli strains isolated from ZU Hospitalswere aligned with sequences of published TEM genes in Ecoli strains from GenBank (eg E coli KM5986651) Theresulting alignments showed 4 different common SNP sitesbetween the different strains The SNPs positions were indi-cated commonly in 216 232 385 and 433 (Figure 4(a)) Phy-logenetic tree was constructed from TEM gene (119887119897119886TEM12)
International Journal of Microbiology 5
AM_372945-22_2-group16-_Vim-group16-_H031-316gi1-390
Consensus
152227
264339
AM_372945-22_2-group16-_Vim-group16-_H031-316gi1-390
Consensus
265340
316390
(a)
AM 372945-22-2-group16-Vim-group16-H03 Ecoli Egypt0000
0000
0000
117376
117339
0037
20
KC4173771
gi Escherichia coli (blaVIM-1) EF0786971 Greece
gi Escherichia coli (blaVIM-1) GU7248711 France
gi Escherichia coli (blaVIM-2) gene KF8566171 Spaingi Escherichia coli blaVIM-1 gene AY7814131 Greece
(b)1111111111
121121121121121121121121121121
361361361361361361361361361361
241241241241241241241241241241
120120120120120120120120120120
240240240240240240240240240240
390390390390390390390390390390
360360360360360360360360360360
Consensus
Consensus
Consensus
Consensus
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
(c)
gi Klebsiella pneumoniae VIM-2 genes |DQ1532171| Koreagi| Klebsiella pneumoniae strain (VIM-1) |GQ4228371| USA
gi Klebsiella pneumoniae plasmid|NG 0362531| USAAM 372945-24 4-group16-Vim-group16-H03 Kpneumonia Egypt
000
0011
00040002
000900090009
DQ1439131
0008 0006 0004 0002 00000010Relative times
gi Klebsiella pneumoniae strain (blaVIM-1) |GQ4228271| USA
(d)
Figure 3 Continued
6 International Journal of Microbiology
168168184168168243243
289289305289289364364
288288304288288363363
317315331315315390390
Consensus
Consensus
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
(e)
gi Acinetobacter baumannii VIM-1 |EF6906951| Greece
AM 372945-23 3-group16-Vim-group16-G03 Abaumanii Egypt0556
0009
0000
00000011
0542
0006
01
JN7005202
gi A baumannii class I integron (blaVIM-1) |EF6906961| Greece
gi Acinetobacter baumannii strain VIM (blaVIM) |JF7029211| India
gi Acinetobacter baumannii strain (blaVIM) |JF7029191| India
(f)
Figure 3Themultiple sequences alignments and trees of VIM gene in different species (a) VIM gene in E coli strains isolated from ZagazigUniversity (ZU) Hospitals in comparison with published VIM gene of E coli strains from GenBank (b) A tree of VIM sequence of E coliisolated from ZU Hospitals and published homologs in GenBank (c) The multiple sequences alignments of VIM gene in K pneumoniaestrains isolated from ZUHospitals in comparison with published VIM gene inK pneumoniae strains fromGenBank (d) Phylogenetic tree ofVIM sequence of K pneumoniae isolated from ZUHospitals and published sequences in GenBank (e)Themultiple sequences alignments ofVIM gene in A baumanii strains isolated from ZUHospitals in comparison with published VIM gene in A baumanii strains from GenBank(f) Phylogenetic tree of VIM sequence of A baumanii isolated from ZU Hospitals and published sequences in GenBank
sequence of Escherichia coli strains isolated from ZU Hos-pitals and published homologous sequences in GenBank(Figure 4(b)) showing similarity degree between Egyptianand Indian strains
(2) TEM Gene (blaTEM12) of Klebsiella pneumonia Multiplesequences alignments of TEM gene inK pneumoniae strainsisolated from ZU Hospitals were compared with other pub-lished TEM genes in K pneumoniae strains from GenBank(eg K pneumoniae KF2683571) (Figure 4(c)) showed 2different common SNPs between different strains The SNPspositions were indicated in 174 and 343 A phylogenetictree of TEM sequence of K pneumoniae isolated fromZagazig University Hospitals and other published ones inGenBank showed the degree of similarity between strainswhere Egyptian strain was dissimilar to that of Iranian andIndian strains (Figure 4(d))
343 The Analysis of SHV Gene (119887119897119886SHV1) in Klebsiellapneumoniae Strains The pairwise sequences alignments ofresulting SHV gene (119887119897119886SHV1) in K pneumoniae strains iso-lated from Zagazig University Hospitals in comparison withpublished SHV gene inK pneumoniae strains fromGenBankusing BLAST program (eg K pneumoniae AF1249841)
showed five common SNPs between the different strainsTheSNPs position was indicated in 454 563 631 635 and 650in Egyptian strains (Figure 5(a)) The phylogenetic tree ofSHV gene in this case showed that Egyptian strain was moresimilar to France strain (Figure 5(b))
344The Analysis of CTX-M-1 Gene (119887119897119886CTX-M-1) Sequencesof the purified product of CTX-M-1 gene (119887119897119886CTX-M-1) werecompared with homologous counterpart GenBank databaseusing BLAST program and resulted in significant similarityto many metallo-120573-lactamases genes of different bacterialstrains
(1) CTX-M-1 Gene (blaCTX-M-1) of Escherichia coli Strains Thesequence of the purified product of CTX-M-1 gene fromEscherichia coli strains was compared with the GenBanksequence using BLASTprogram Interestingly it was revealedthat there were strains present in GenBank which are com-pletely different from the studied strains and this is notmatchingwith our study (egPseudomonas aeruginosaDNAAP0146461) The sequence alignment showed 81 differentcommon SNPs between the different strains The SNPspositions were indicated in 601 604rarr 615 617rarr 626 and628rarr 688 (Figure 6(a)) The phylogenetic tree of CTX-M-1
International Journal of Microbiology 7
91115115115
205229229229
319343343343
433457457457
547571571571
204228228228
318342342342
432456456456
546570570570
660684684684
Consensus
Consensus
Consensus
Consensus
Consensus
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
(a)
TEM Ecoli Egypt
00041
0002700000
00014
00005
KM5986651gi|675594620|gb|KJ9230021| Escherichia coli strain blaTEM (blaTEM-1) India
gi|383282208|gb|JQ8231751| Escherichia beta-lactamase TEM (blaTEM) India
gi|347810716|gb|JN1883651| Escherichia coli strain ARY 4 blaTEM gene India
(b)115102111111111111111
229216225225225225225
343330339339339339339
228215224224
342329338338338338338
456443452452452452452
224224224
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
Consensus
Consensus
Consensus
(c)
AM 372945-26 6-group16-T-group16-B04 Kpneumonia Egypt00022
00033
00000
00000
00000
00000
00000
0001500004
00015
00005
00005
KF2683571gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346951| Iran
gi Klebsiella pneumoniae beta-lactamase TEM-1 (blaTem) |GQ4704601| Irangi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |GU7346961| Iran
gi Klebsiella pneumoniae strain TEM-1 (blaTem) gene |GU7346941| Iran
gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346901| Iran
gi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |JN0433841| India
(d)
Figure 4 The multiple sequences alignments and trees of TEM gene (119887119897119886TEM12) in different bacterial species (a) TEM gene in E coli strainsisolated fromZUHospitals in comparisonwith publishedTEMgene ofE coli strains fromGenBank (b)Aphylogenetic tree of TEMgene ofEcoli isolated fromZUHospitals and published homologous ones inGenBank (c)Themultiple sequences alignments of gene inK pneumoniaestrains isolated from ZU Hospitals in comparison with published TEM gene in K pneumoniae strains from GenBank (d) Phylogenetic treeof sequence of K pneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
8 International Journal of Microbiology
340
340340340340
340340
453
453453453453
453453
566
566566566566
566566
324
324324
211
211211
98
9898
452
452452452452
452452
210
210210
565
565565565
565565
565
323
323323
678
678678678678
678678
436
436436
Consensus
Consensus
Consensus
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
(a)
gi Klebsiella pneumoniae conjugative plasmid beta-lactamase SHV-13 (bla) gene |AF1645771| UK
AM_372945-30 13-group16-T-group16-A04 Ecloacae Egypt
gi Klebsiella pneumoniae beta-lactamase SHV-14 (bla) gene |AF2266221| UK
00000
00022
00087
00022
00000
00000
000000004300000
0002200022
00022
00022
00000
0001
AF1249841
gi Klebsiella pneumoniae extended spectrum beta-lactamase SHV-1 (blaSHV) gene |HM0605401| Iran
gi Klebsiella pneumoniae strain K16R SHV-1 beta-lactamase (blaSHV) gene |HM7511021| Brazil
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-11 (blaSHV) |GQ4704281| Iran
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-1 (blaSHV) |HM0605381| Iran
gi Klebsiella pneumoniae plasmid blaSHV gene for beta-lactamase SHV |AB6757231| Japan
gi Klebsiella pneumoniae blaSHV type 1 gene complete cds|DQ3557841| Brazil
gi Klebsiella pneumoniae blaSHV gene for beta-lactamase class A |Y110691| France
(b)
Figure 5Themultiple sequences alignments and trees of SHV gene in different species (a) SHV gene inK pneumoniae strains isolated fromZUHospitals in comparison with published SHV gene of K pneumoniae strains from GenBank (b) Phylogenetic tree of SHV sequence of Kpneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
sequence of E coli isolated fromZagazig University Hospitalsand published homologous ones in GenBank showed dissim-ilarity degree between Egyptian and other universal strains(Figure 6(b))
(2) CTX-M-1 Gene (blaCTX-M-1) of Klebsiella pneumoniaeStrains The alignment in this case showed 39 differentcommon SNPs between the different strains The SNPspositions were indicated in positions 1 rarr 39 (Figure 6(c))A phylogenetic tree of CTX-M-1 gene sequence in K pneu-moniae strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed different degrees
of dissimilarity between the different strains with manyunique sequences in Egyptian strain (Figure 6(d))
(3) CTX-M-1 Gene (blaCTX-M-1) of Pseudomonas aeruginosaStrainsTheCTX-M-1 gene isolated fromP aeruginosa strainsin Zagazig University Hospitals was compared using BLASTprogram with published CTX-M-1 gene in P aeruginosastrains from GenBank (eg Paeruginosa KC5712551) Theresults showed 4 different common SNPs between the differ-ent strainsThe SNPs positions were indicated in 117 206 228and 283 (Figure 6(e)) A phylogenetic tree showed similaritydegree between Egyptian and Russian strains (Figure 6(f))
International Journal of Microbiology 9
601601601601
629688688688
Consensus
CTX11-629gi|695214033|ref|NG_0367291|1-688gi|224696954|emb|FM2133711|1-688gi|402795953|dbj|AB7015731|1-688
(a)
CTX1 Ecoli Egypt05168
00000
00000
0000005168
01
AP0146461
gi |NG 0367291| Escherichia coli blaCTX-M-3 gene for beta-lactamase USA
gi Escherichia coli DNA ISEcp1-blaCTX-M-15 |AB7015731| Japan
gi Escherichia coli blaCTX-M-3 gene for beta-lactamase |FM2133711| Poland
(b)227
2911
340142
3391417474
452254187187
7575
Consensus
Consensus
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
(c)
gi Klebsiella pneumoniae strain 285L extended spectrum beta-lactamase CTX-M-15 |GQ4704351|Iran
CTX1 Klebsiella pneumoniae Egyptgi Klebsiella pneumoniae strain 212L extended spectrum beta-lactamase CTX-M-15 |GQ4704311| Irangi Klebsiella pneumoniae CTX-M-15|GQ8655681| India
00000
0000000000
07585
07515
00070
02
KJ4514101
gi Klebsiella pneumoniae (blaCTX-M-15) gene |EU5567551|Hungary
(d)56
113113
167224224
279336336
391448448
168225225
280337337
Consensus
Consensus
Consensus
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
(e)
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia(2)CTX1 Pseudomonas aeruginosa Egypt00024
00000
0000000024
00005
KC5712551
(f)
Figure 6 The multiple sequences alignments and trees of CTX-M-1 gene in different species (a) CTX-M-1 gene in E coli strains isolatedfrom ZU Hospitals in comparison with published CTX-M-1 gene of E coli strains from GenBank (b) A tree of CTX-M-1 sequence of E coliisolated from ZUHospitals and published homologs in GenBank (c)Themultiple sequences alignments of CTX-M-1 gene in K pneumoniaestrains isolated from ZU Hospitals in comparison with published CTX-M-1 gene in K pneumoniae strains from GenBank (d) Phylogenetictree of CTX-M-1 sequence of K pneumoniae isolated from ZU Hospitals and published homologous sequences in GenBank (e) Multiplesequences alignments of CTX-M-1 gene in P aeruginosa strains isolated from ZU Hospitals in comparison with published CTX-M-1 gene inP aeruginosa strains from GenBank (f) Phylogenetic tree of CTX-M-1 sequence of P aeruginosa isolated from ZU Hospitals and publishedhomologs in GenBank
10 International Journal of Microbiology
11111
113113113113113
225225225225225
Consensus
Consensus
Consensus
112112112112112
224224224224224
336336336336336
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
(a)
00000
00000
00037
00037
00005
JN6768431
AM 372945-35 21-group16- g9-group16- C05 (830bp) Ecoli Egypt
gi Escherichia coli (blaCTX-M-9b) gene complete cds |EU4189151|Australia
gi Escherichia coli strain K-340 (blaCTX-M-9) gene complete cds |HM5697351|Russia
gi Escherichia coli DNA blaCTX-M-14 gene |AB9765961|Japan
(b)
Figure 7Themultiple sequences alignments and tree of CTX-M-9 gene in different species (a) CTX-M-9 gene in E coli strains isolated fromZU Hospitals in comparison with published CTX-M-9 gene of E coli strains from GenBank (b) Phylogenetic tree of CTX-M-9 sequence ofE coli isolated from ZU Hospitals and published homologous ones in GenBank
345 The Analysis of CTX-M-9 Gene (119887119897119886CTX-M-9) inEscherichia coli Strains The CTX-M-9 gene isolated fromE coli strains in Zagazig University Hospitals was comparedwith published CTX-M-1 gene in P aeruginosa strains fromGenBank using BLAST program (eg E coli JN6768431)The multiple sequences alignments showed 2 differentcommon SNPs in positions 74 and 272 (Figure 7(a))The phylogenetic tree of CTX-M-9 gene sequence in Ecoli strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed differentdegrees of dissimilarity between the different strains andmany unique sequences in the Egyptian strain similar tothat of Russia and Australia and dissimilar to that of Japan(Figure 7(b))
4 Discussion
The Gram-negative bacilli are among the most importantcauses of serious nosocomial and community-onset bacte-rial infections in humans and antimicrobial resistance hasbecome a global threat to effective health care delivery [14]However carbapenem-resistant Gram-negative bacilli havebeen increasingly reported worldwide [4] Various acquiredcarbapenemases have been identified in the last years belong-ing to either acquired metallo-beta-lactamases (IMP VIM
Table 2 The distribution of Gram-negative bacilli isolates in eachclinical specimen
Clinical specimens Gram-negative bacilli isolatesType Number Number ()Urine 52 41 788Blood 18 12 666Sputum 29 10 345Pus 9 2 222Total 108 65 (602)1205942= 2128 119875 lt 0001 (statistically significant)
SPM GIM NDM andDIM types) or class A (KPC andGES)and class D 120573-lactamase OXA-48 [15]
In the present study prevalence of 120573-lactamases-producing isolates was found in Table 2 Different studiescarried out by other workers in various parts of the worldshow quite variable results In a study carried out thefrequency of beta-lactamases-producing isolates was urine(61) followed by blood cultures (38) wound swabs (13)and tracheal aspirates (5) (119875 lt 0001) [16] And this issimilar to our study By contrast Shanthi and Sekar [17] inIndia reported that Gram-negative isolates were obtainedfrom the respiratory tract (418) followed by urinary tract
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
International Journal of Microbiology 5
AM_372945-22_2-group16-_Vim-group16-_H031-316gi1-390
Consensus
152227
264339
AM_372945-22_2-group16-_Vim-group16-_H031-316gi1-390
Consensus
265340
316390
(a)
AM 372945-22-2-group16-Vim-group16-H03 Ecoli Egypt0000
0000
0000
117376
117339
0037
20
KC4173771
gi Escherichia coli (blaVIM-1) EF0786971 Greece
gi Escherichia coli (blaVIM-1) GU7248711 France
gi Escherichia coli (blaVIM-2) gene KF8566171 Spaingi Escherichia coli blaVIM-1 gene AY7814131 Greece
(b)1111111111
121121121121121121121121121121
361361361361361361361361361361
241241241241241241241241241241
120120120120120120120120120120
240240240240240240240240240240
390390390390390390390390390390
360360360360360360360360360360
Consensus
Consensus
Consensus
Consensus
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
gi1-390Contig 11-390
gi1-390gi|695214489|ref|NG_0368121|1-390gi|257043832|gb|GQ4228271|1-390gi|257043832|gb|GQ4228271|1-390
gi|73747120|gb|DQ1532171|1-390gi|73747126|gb|DQ1532181|1-390
gi|695211273|ref|NG_0360511|1-390gi|695211797|ref|NG_0362531|1-390
(c)
gi Klebsiella pneumoniae VIM-2 genes |DQ1532171| Koreagi| Klebsiella pneumoniae strain (VIM-1) |GQ4228371| USA
gi Klebsiella pneumoniae plasmid|NG 0362531| USAAM 372945-24 4-group16-Vim-group16-H03 Kpneumonia Egypt
000
0011
00040002
000900090009
DQ1439131
0008 0006 0004 0002 00000010Relative times
gi Klebsiella pneumoniae strain (blaVIM-1) |GQ4228271| USA
(d)
Figure 3 Continued
6 International Journal of Microbiology
168168184168168243243
289289305289289364364
288288304288288363363
317315331315315390390
Consensus
Consensus
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
(e)
gi Acinetobacter baumannii VIM-1 |EF6906951| Greece
AM 372945-23 3-group16-Vim-group16-G03 Abaumanii Egypt0556
0009
0000
00000011
0542
0006
01
JN7005202
gi A baumannii class I integron (blaVIM-1) |EF6906961| Greece
gi Acinetobacter baumannii strain VIM (blaVIM) |JF7029211| India
gi Acinetobacter baumannii strain (blaVIM) |JF7029191| India
(f)
Figure 3Themultiple sequences alignments and trees of VIM gene in different species (a) VIM gene in E coli strains isolated from ZagazigUniversity (ZU) Hospitals in comparison with published VIM gene of E coli strains from GenBank (b) A tree of VIM sequence of E coliisolated from ZU Hospitals and published homologs in GenBank (c) The multiple sequences alignments of VIM gene in K pneumoniaestrains isolated from ZUHospitals in comparison with published VIM gene inK pneumoniae strains fromGenBank (d) Phylogenetic tree ofVIM sequence of K pneumoniae isolated from ZUHospitals and published sequences in GenBank (e)Themultiple sequences alignments ofVIM gene in A baumanii strains isolated from ZUHospitals in comparison with published VIM gene in A baumanii strains from GenBank(f) Phylogenetic tree of VIM sequence of A baumanii isolated from ZU Hospitals and published sequences in GenBank
sequence of Escherichia coli strains isolated from ZU Hos-pitals and published homologous sequences in GenBank(Figure 4(b)) showing similarity degree between Egyptianand Indian strains
(2) TEM Gene (blaTEM12) of Klebsiella pneumonia Multiplesequences alignments of TEM gene inK pneumoniae strainsisolated from ZU Hospitals were compared with other pub-lished TEM genes in K pneumoniae strains from GenBank(eg K pneumoniae KF2683571) (Figure 4(c)) showed 2different common SNPs between different strains The SNPspositions were indicated in 174 and 343 A phylogenetictree of TEM sequence of K pneumoniae isolated fromZagazig University Hospitals and other published ones inGenBank showed the degree of similarity between strainswhere Egyptian strain was dissimilar to that of Iranian andIndian strains (Figure 4(d))
343 The Analysis of SHV Gene (119887119897119886SHV1) in Klebsiellapneumoniae Strains The pairwise sequences alignments ofresulting SHV gene (119887119897119886SHV1) in K pneumoniae strains iso-lated from Zagazig University Hospitals in comparison withpublished SHV gene inK pneumoniae strains fromGenBankusing BLAST program (eg K pneumoniae AF1249841)
showed five common SNPs between the different strainsTheSNPs position was indicated in 454 563 631 635 and 650in Egyptian strains (Figure 5(a)) The phylogenetic tree ofSHV gene in this case showed that Egyptian strain was moresimilar to France strain (Figure 5(b))
344The Analysis of CTX-M-1 Gene (119887119897119886CTX-M-1) Sequencesof the purified product of CTX-M-1 gene (119887119897119886CTX-M-1) werecompared with homologous counterpart GenBank databaseusing BLAST program and resulted in significant similarityto many metallo-120573-lactamases genes of different bacterialstrains
(1) CTX-M-1 Gene (blaCTX-M-1) of Escherichia coli Strains Thesequence of the purified product of CTX-M-1 gene fromEscherichia coli strains was compared with the GenBanksequence using BLASTprogram Interestingly it was revealedthat there were strains present in GenBank which are com-pletely different from the studied strains and this is notmatchingwith our study (egPseudomonas aeruginosaDNAAP0146461) The sequence alignment showed 81 differentcommon SNPs between the different strains The SNPspositions were indicated in 601 604rarr 615 617rarr 626 and628rarr 688 (Figure 6(a)) The phylogenetic tree of CTX-M-1
International Journal of Microbiology 7
91115115115
205229229229
319343343343
433457457457
547571571571
204228228228
318342342342
432456456456
546570570570
660684684684
Consensus
Consensus
Consensus
Consensus
Consensus
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
(a)
TEM Ecoli Egypt
00041
0002700000
00014
00005
KM5986651gi|675594620|gb|KJ9230021| Escherichia coli strain blaTEM (blaTEM-1) India
gi|383282208|gb|JQ8231751| Escherichia beta-lactamase TEM (blaTEM) India
gi|347810716|gb|JN1883651| Escherichia coli strain ARY 4 blaTEM gene India
(b)115102111111111111111
229216225225225225225
343330339339339339339
228215224224
342329338338338338338
456443452452452452452
224224224
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
Consensus
Consensus
Consensus
(c)
AM 372945-26 6-group16-T-group16-B04 Kpneumonia Egypt00022
00033
00000
00000
00000
00000
00000
0001500004
00015
00005
00005
KF2683571gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346951| Iran
gi Klebsiella pneumoniae beta-lactamase TEM-1 (blaTem) |GQ4704601| Irangi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |GU7346961| Iran
gi Klebsiella pneumoniae strain TEM-1 (blaTem) gene |GU7346941| Iran
gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346901| Iran
gi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |JN0433841| India
(d)
Figure 4 The multiple sequences alignments and trees of TEM gene (119887119897119886TEM12) in different bacterial species (a) TEM gene in E coli strainsisolated fromZUHospitals in comparisonwith publishedTEMgene ofE coli strains fromGenBank (b)Aphylogenetic tree of TEMgene ofEcoli isolated fromZUHospitals and published homologous ones inGenBank (c)Themultiple sequences alignments of gene inK pneumoniaestrains isolated from ZU Hospitals in comparison with published TEM gene in K pneumoniae strains from GenBank (d) Phylogenetic treeof sequence of K pneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
8 International Journal of Microbiology
340
340340340340
340340
453
453453453453
453453
566
566566566566
566566
324
324324
211
211211
98
9898
452
452452452452
452452
210
210210
565
565565565
565565
565
323
323323
678
678678678678
678678
436
436436
Consensus
Consensus
Consensus
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
(a)
gi Klebsiella pneumoniae conjugative plasmid beta-lactamase SHV-13 (bla) gene |AF1645771| UK
AM_372945-30 13-group16-T-group16-A04 Ecloacae Egypt
gi Klebsiella pneumoniae beta-lactamase SHV-14 (bla) gene |AF2266221| UK
00000
00022
00087
00022
00000
00000
000000004300000
0002200022
00022
00022
00000
0001
AF1249841
gi Klebsiella pneumoniae extended spectrum beta-lactamase SHV-1 (blaSHV) gene |HM0605401| Iran
gi Klebsiella pneumoniae strain K16R SHV-1 beta-lactamase (blaSHV) gene |HM7511021| Brazil
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-11 (blaSHV) |GQ4704281| Iran
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-1 (blaSHV) |HM0605381| Iran
gi Klebsiella pneumoniae plasmid blaSHV gene for beta-lactamase SHV |AB6757231| Japan
gi Klebsiella pneumoniae blaSHV type 1 gene complete cds|DQ3557841| Brazil
gi Klebsiella pneumoniae blaSHV gene for beta-lactamase class A |Y110691| France
(b)
Figure 5Themultiple sequences alignments and trees of SHV gene in different species (a) SHV gene inK pneumoniae strains isolated fromZUHospitals in comparison with published SHV gene of K pneumoniae strains from GenBank (b) Phylogenetic tree of SHV sequence of Kpneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
sequence of E coli isolated fromZagazig University Hospitalsand published homologous ones in GenBank showed dissim-ilarity degree between Egyptian and other universal strains(Figure 6(b))
(2) CTX-M-1 Gene (blaCTX-M-1) of Klebsiella pneumoniaeStrains The alignment in this case showed 39 differentcommon SNPs between the different strains The SNPspositions were indicated in positions 1 rarr 39 (Figure 6(c))A phylogenetic tree of CTX-M-1 gene sequence in K pneu-moniae strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed different degrees
of dissimilarity between the different strains with manyunique sequences in Egyptian strain (Figure 6(d))
(3) CTX-M-1 Gene (blaCTX-M-1) of Pseudomonas aeruginosaStrainsTheCTX-M-1 gene isolated fromP aeruginosa strainsin Zagazig University Hospitals was compared using BLASTprogram with published CTX-M-1 gene in P aeruginosastrains from GenBank (eg Paeruginosa KC5712551) Theresults showed 4 different common SNPs between the differ-ent strainsThe SNPs positions were indicated in 117 206 228and 283 (Figure 6(e)) A phylogenetic tree showed similaritydegree between Egyptian and Russian strains (Figure 6(f))
International Journal of Microbiology 9
601601601601
629688688688
Consensus
CTX11-629gi|695214033|ref|NG_0367291|1-688gi|224696954|emb|FM2133711|1-688gi|402795953|dbj|AB7015731|1-688
(a)
CTX1 Ecoli Egypt05168
00000
00000
0000005168
01
AP0146461
gi |NG 0367291| Escherichia coli blaCTX-M-3 gene for beta-lactamase USA
gi Escherichia coli DNA ISEcp1-blaCTX-M-15 |AB7015731| Japan
gi Escherichia coli blaCTX-M-3 gene for beta-lactamase |FM2133711| Poland
(b)227
2911
340142
3391417474
452254187187
7575
Consensus
Consensus
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
(c)
gi Klebsiella pneumoniae strain 285L extended spectrum beta-lactamase CTX-M-15 |GQ4704351|Iran
CTX1 Klebsiella pneumoniae Egyptgi Klebsiella pneumoniae strain 212L extended spectrum beta-lactamase CTX-M-15 |GQ4704311| Irangi Klebsiella pneumoniae CTX-M-15|GQ8655681| India
00000
0000000000
07585
07515
00070
02
KJ4514101
gi Klebsiella pneumoniae (blaCTX-M-15) gene |EU5567551|Hungary
(d)56
113113
167224224
279336336
391448448
168225225
280337337
Consensus
Consensus
Consensus
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
(e)
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia(2)CTX1 Pseudomonas aeruginosa Egypt00024
00000
0000000024
00005
KC5712551
(f)
Figure 6 The multiple sequences alignments and trees of CTX-M-1 gene in different species (a) CTX-M-1 gene in E coli strains isolatedfrom ZU Hospitals in comparison with published CTX-M-1 gene of E coli strains from GenBank (b) A tree of CTX-M-1 sequence of E coliisolated from ZUHospitals and published homologs in GenBank (c)Themultiple sequences alignments of CTX-M-1 gene in K pneumoniaestrains isolated from ZU Hospitals in comparison with published CTX-M-1 gene in K pneumoniae strains from GenBank (d) Phylogenetictree of CTX-M-1 sequence of K pneumoniae isolated from ZU Hospitals and published homologous sequences in GenBank (e) Multiplesequences alignments of CTX-M-1 gene in P aeruginosa strains isolated from ZU Hospitals in comparison with published CTX-M-1 gene inP aeruginosa strains from GenBank (f) Phylogenetic tree of CTX-M-1 sequence of P aeruginosa isolated from ZU Hospitals and publishedhomologs in GenBank
10 International Journal of Microbiology
11111
113113113113113
225225225225225
Consensus
Consensus
Consensus
112112112112112
224224224224224
336336336336336
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
(a)
00000
00000
00037
00037
00005
JN6768431
AM 372945-35 21-group16- g9-group16- C05 (830bp) Ecoli Egypt
gi Escherichia coli (blaCTX-M-9b) gene complete cds |EU4189151|Australia
gi Escherichia coli strain K-340 (blaCTX-M-9) gene complete cds |HM5697351|Russia
gi Escherichia coli DNA blaCTX-M-14 gene |AB9765961|Japan
(b)
Figure 7Themultiple sequences alignments and tree of CTX-M-9 gene in different species (a) CTX-M-9 gene in E coli strains isolated fromZU Hospitals in comparison with published CTX-M-9 gene of E coli strains from GenBank (b) Phylogenetic tree of CTX-M-9 sequence ofE coli isolated from ZU Hospitals and published homologous ones in GenBank
345 The Analysis of CTX-M-9 Gene (119887119897119886CTX-M-9) inEscherichia coli Strains The CTX-M-9 gene isolated fromE coli strains in Zagazig University Hospitals was comparedwith published CTX-M-1 gene in P aeruginosa strains fromGenBank using BLAST program (eg E coli JN6768431)The multiple sequences alignments showed 2 differentcommon SNPs in positions 74 and 272 (Figure 7(a))The phylogenetic tree of CTX-M-9 gene sequence in Ecoli strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed differentdegrees of dissimilarity between the different strains andmany unique sequences in the Egyptian strain similar tothat of Russia and Australia and dissimilar to that of Japan(Figure 7(b))
4 Discussion
The Gram-negative bacilli are among the most importantcauses of serious nosocomial and community-onset bacte-rial infections in humans and antimicrobial resistance hasbecome a global threat to effective health care delivery [14]However carbapenem-resistant Gram-negative bacilli havebeen increasingly reported worldwide [4] Various acquiredcarbapenemases have been identified in the last years belong-ing to either acquired metallo-beta-lactamases (IMP VIM
Table 2 The distribution of Gram-negative bacilli isolates in eachclinical specimen
Clinical specimens Gram-negative bacilli isolatesType Number Number ()Urine 52 41 788Blood 18 12 666Sputum 29 10 345Pus 9 2 222Total 108 65 (602)1205942= 2128 119875 lt 0001 (statistically significant)
SPM GIM NDM andDIM types) or class A (KPC andGES)and class D 120573-lactamase OXA-48 [15]
In the present study prevalence of 120573-lactamases-producing isolates was found in Table 2 Different studiescarried out by other workers in various parts of the worldshow quite variable results In a study carried out thefrequency of beta-lactamases-producing isolates was urine(61) followed by blood cultures (38) wound swabs (13)and tracheal aspirates (5) (119875 lt 0001) [16] And this issimilar to our study By contrast Shanthi and Sekar [17] inIndia reported that Gram-negative isolates were obtainedfrom the respiratory tract (418) followed by urinary tract
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
6 International Journal of Microbiology
168168184168168243243
289289305289289364364
288288304288288363363
317315331315315390390
Consensus
Consensus
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
Contig 11-317
gi|336171074|gb|JF7029191|1-315gi|336171074|gb|JF7029191|1-315gi|151564628|gb|EF6906961|1-390gi|151564622|gb|EF6906951|1-390
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
gi|336171078|gb|JF7029211|1-331gi|336171074|gb|JF7029191|1-315
(e)
gi Acinetobacter baumannii VIM-1 |EF6906951| Greece
AM 372945-23 3-group16-Vim-group16-G03 Abaumanii Egypt0556
0009
0000
00000011
0542
0006
01
JN7005202
gi A baumannii class I integron (blaVIM-1) |EF6906961| Greece
gi Acinetobacter baumannii strain VIM (blaVIM) |JF7029211| India
gi Acinetobacter baumannii strain (blaVIM) |JF7029191| India
(f)
Figure 3Themultiple sequences alignments and trees of VIM gene in different species (a) VIM gene in E coli strains isolated from ZagazigUniversity (ZU) Hospitals in comparison with published VIM gene of E coli strains from GenBank (b) A tree of VIM sequence of E coliisolated from ZU Hospitals and published homologs in GenBank (c) The multiple sequences alignments of VIM gene in K pneumoniaestrains isolated from ZUHospitals in comparison with published VIM gene inK pneumoniae strains fromGenBank (d) Phylogenetic tree ofVIM sequence of K pneumoniae isolated from ZUHospitals and published sequences in GenBank (e)Themultiple sequences alignments ofVIM gene in A baumanii strains isolated from ZUHospitals in comparison with published VIM gene in A baumanii strains from GenBank(f) Phylogenetic tree of VIM sequence of A baumanii isolated from ZU Hospitals and published sequences in GenBank
sequence of Escherichia coli strains isolated from ZU Hos-pitals and published homologous sequences in GenBank(Figure 4(b)) showing similarity degree between Egyptianand Indian strains
(2) TEM Gene (blaTEM12) of Klebsiella pneumonia Multiplesequences alignments of TEM gene inK pneumoniae strainsisolated from ZU Hospitals were compared with other pub-lished TEM genes in K pneumoniae strains from GenBank(eg K pneumoniae KF2683571) (Figure 4(c)) showed 2different common SNPs between different strains The SNPspositions were indicated in 174 and 343 A phylogenetictree of TEM sequence of K pneumoniae isolated fromZagazig University Hospitals and other published ones inGenBank showed the degree of similarity between strainswhere Egyptian strain was dissimilar to that of Iranian andIndian strains (Figure 4(d))
343 The Analysis of SHV Gene (119887119897119886SHV1) in Klebsiellapneumoniae Strains The pairwise sequences alignments ofresulting SHV gene (119887119897119886SHV1) in K pneumoniae strains iso-lated from Zagazig University Hospitals in comparison withpublished SHV gene inK pneumoniae strains fromGenBankusing BLAST program (eg K pneumoniae AF1249841)
showed five common SNPs between the different strainsTheSNPs position was indicated in 454 563 631 635 and 650in Egyptian strains (Figure 5(a)) The phylogenetic tree ofSHV gene in this case showed that Egyptian strain was moresimilar to France strain (Figure 5(b))
344The Analysis of CTX-M-1 Gene (119887119897119886CTX-M-1) Sequencesof the purified product of CTX-M-1 gene (119887119897119886CTX-M-1) werecompared with homologous counterpart GenBank databaseusing BLAST program and resulted in significant similarityto many metallo-120573-lactamases genes of different bacterialstrains
(1) CTX-M-1 Gene (blaCTX-M-1) of Escherichia coli Strains Thesequence of the purified product of CTX-M-1 gene fromEscherichia coli strains was compared with the GenBanksequence using BLASTprogram Interestingly it was revealedthat there were strains present in GenBank which are com-pletely different from the studied strains and this is notmatchingwith our study (egPseudomonas aeruginosaDNAAP0146461) The sequence alignment showed 81 differentcommon SNPs between the different strains The SNPspositions were indicated in 601 604rarr 615 617rarr 626 and628rarr 688 (Figure 6(a)) The phylogenetic tree of CTX-M-1
International Journal of Microbiology 7
91115115115
205229229229
319343343343
433457457457
547571571571
204228228228
318342342342
432456456456
546570570570
660684684684
Consensus
Consensus
Consensus
Consensus
Consensus
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
(a)
TEM Ecoli Egypt
00041
0002700000
00014
00005
KM5986651gi|675594620|gb|KJ9230021| Escherichia coli strain blaTEM (blaTEM-1) India
gi|383282208|gb|JQ8231751| Escherichia beta-lactamase TEM (blaTEM) India
gi|347810716|gb|JN1883651| Escherichia coli strain ARY 4 blaTEM gene India
(b)115102111111111111111
229216225225225225225
343330339339339339339
228215224224
342329338338338338338
456443452452452452452
224224224
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
Consensus
Consensus
Consensus
(c)
AM 372945-26 6-group16-T-group16-B04 Kpneumonia Egypt00022
00033
00000
00000
00000
00000
00000
0001500004
00015
00005
00005
KF2683571gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346951| Iran
gi Klebsiella pneumoniae beta-lactamase TEM-1 (blaTem) |GQ4704601| Irangi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |GU7346961| Iran
gi Klebsiella pneumoniae strain TEM-1 (blaTem) gene |GU7346941| Iran
gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346901| Iran
gi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |JN0433841| India
(d)
Figure 4 The multiple sequences alignments and trees of TEM gene (119887119897119886TEM12) in different bacterial species (a) TEM gene in E coli strainsisolated fromZUHospitals in comparisonwith publishedTEMgene ofE coli strains fromGenBank (b)Aphylogenetic tree of TEMgene ofEcoli isolated fromZUHospitals and published homologous ones inGenBank (c)Themultiple sequences alignments of gene inK pneumoniaestrains isolated from ZU Hospitals in comparison with published TEM gene in K pneumoniae strains from GenBank (d) Phylogenetic treeof sequence of K pneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
8 International Journal of Microbiology
340
340340340340
340340
453
453453453453
453453
566
566566566566
566566
324
324324
211
211211
98
9898
452
452452452452
452452
210
210210
565
565565565
565565
565
323
323323
678
678678678678
678678
436
436436
Consensus
Consensus
Consensus
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
(a)
gi Klebsiella pneumoniae conjugative plasmid beta-lactamase SHV-13 (bla) gene |AF1645771| UK
AM_372945-30 13-group16-T-group16-A04 Ecloacae Egypt
gi Klebsiella pneumoniae beta-lactamase SHV-14 (bla) gene |AF2266221| UK
00000
00022
00087
00022
00000
00000
000000004300000
0002200022
00022
00022
00000
0001
AF1249841
gi Klebsiella pneumoniae extended spectrum beta-lactamase SHV-1 (blaSHV) gene |HM0605401| Iran
gi Klebsiella pneumoniae strain K16R SHV-1 beta-lactamase (blaSHV) gene |HM7511021| Brazil
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-11 (blaSHV) |GQ4704281| Iran
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-1 (blaSHV) |HM0605381| Iran
gi Klebsiella pneumoniae plasmid blaSHV gene for beta-lactamase SHV |AB6757231| Japan
gi Klebsiella pneumoniae blaSHV type 1 gene complete cds|DQ3557841| Brazil
gi Klebsiella pneumoniae blaSHV gene for beta-lactamase class A |Y110691| France
(b)
Figure 5Themultiple sequences alignments and trees of SHV gene in different species (a) SHV gene inK pneumoniae strains isolated fromZUHospitals in comparison with published SHV gene of K pneumoniae strains from GenBank (b) Phylogenetic tree of SHV sequence of Kpneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
sequence of E coli isolated fromZagazig University Hospitalsand published homologous ones in GenBank showed dissim-ilarity degree between Egyptian and other universal strains(Figure 6(b))
(2) CTX-M-1 Gene (blaCTX-M-1) of Klebsiella pneumoniaeStrains The alignment in this case showed 39 differentcommon SNPs between the different strains The SNPspositions were indicated in positions 1 rarr 39 (Figure 6(c))A phylogenetic tree of CTX-M-1 gene sequence in K pneu-moniae strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed different degrees
of dissimilarity between the different strains with manyunique sequences in Egyptian strain (Figure 6(d))
(3) CTX-M-1 Gene (blaCTX-M-1) of Pseudomonas aeruginosaStrainsTheCTX-M-1 gene isolated fromP aeruginosa strainsin Zagazig University Hospitals was compared using BLASTprogram with published CTX-M-1 gene in P aeruginosastrains from GenBank (eg Paeruginosa KC5712551) Theresults showed 4 different common SNPs between the differ-ent strainsThe SNPs positions were indicated in 117 206 228and 283 (Figure 6(e)) A phylogenetic tree showed similaritydegree between Egyptian and Russian strains (Figure 6(f))
International Journal of Microbiology 9
601601601601
629688688688
Consensus
CTX11-629gi|695214033|ref|NG_0367291|1-688gi|224696954|emb|FM2133711|1-688gi|402795953|dbj|AB7015731|1-688
(a)
CTX1 Ecoli Egypt05168
00000
00000
0000005168
01
AP0146461
gi |NG 0367291| Escherichia coli blaCTX-M-3 gene for beta-lactamase USA
gi Escherichia coli DNA ISEcp1-blaCTX-M-15 |AB7015731| Japan
gi Escherichia coli blaCTX-M-3 gene for beta-lactamase |FM2133711| Poland
(b)227
2911
340142
3391417474
452254187187
7575
Consensus
Consensus
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
(c)
gi Klebsiella pneumoniae strain 285L extended spectrum beta-lactamase CTX-M-15 |GQ4704351|Iran
CTX1 Klebsiella pneumoniae Egyptgi Klebsiella pneumoniae strain 212L extended spectrum beta-lactamase CTX-M-15 |GQ4704311| Irangi Klebsiella pneumoniae CTX-M-15|GQ8655681| India
00000
0000000000
07585
07515
00070
02
KJ4514101
gi Klebsiella pneumoniae (blaCTX-M-15) gene |EU5567551|Hungary
(d)56
113113
167224224
279336336
391448448
168225225
280337337
Consensus
Consensus
Consensus
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
(e)
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia(2)CTX1 Pseudomonas aeruginosa Egypt00024
00000
0000000024
00005
KC5712551
(f)
Figure 6 The multiple sequences alignments and trees of CTX-M-1 gene in different species (a) CTX-M-1 gene in E coli strains isolatedfrom ZU Hospitals in comparison with published CTX-M-1 gene of E coli strains from GenBank (b) A tree of CTX-M-1 sequence of E coliisolated from ZUHospitals and published homologs in GenBank (c)Themultiple sequences alignments of CTX-M-1 gene in K pneumoniaestrains isolated from ZU Hospitals in comparison with published CTX-M-1 gene in K pneumoniae strains from GenBank (d) Phylogenetictree of CTX-M-1 sequence of K pneumoniae isolated from ZU Hospitals and published homologous sequences in GenBank (e) Multiplesequences alignments of CTX-M-1 gene in P aeruginosa strains isolated from ZU Hospitals in comparison with published CTX-M-1 gene inP aeruginosa strains from GenBank (f) Phylogenetic tree of CTX-M-1 sequence of P aeruginosa isolated from ZU Hospitals and publishedhomologs in GenBank
10 International Journal of Microbiology
11111
113113113113113
225225225225225
Consensus
Consensus
Consensus
112112112112112
224224224224224
336336336336336
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
(a)
00000
00000
00037
00037
00005
JN6768431
AM 372945-35 21-group16- g9-group16- C05 (830bp) Ecoli Egypt
gi Escherichia coli (blaCTX-M-9b) gene complete cds |EU4189151|Australia
gi Escherichia coli strain K-340 (blaCTX-M-9) gene complete cds |HM5697351|Russia
gi Escherichia coli DNA blaCTX-M-14 gene |AB9765961|Japan
(b)
Figure 7Themultiple sequences alignments and tree of CTX-M-9 gene in different species (a) CTX-M-9 gene in E coli strains isolated fromZU Hospitals in comparison with published CTX-M-9 gene of E coli strains from GenBank (b) Phylogenetic tree of CTX-M-9 sequence ofE coli isolated from ZU Hospitals and published homologous ones in GenBank
345 The Analysis of CTX-M-9 Gene (119887119897119886CTX-M-9) inEscherichia coli Strains The CTX-M-9 gene isolated fromE coli strains in Zagazig University Hospitals was comparedwith published CTX-M-1 gene in P aeruginosa strains fromGenBank using BLAST program (eg E coli JN6768431)The multiple sequences alignments showed 2 differentcommon SNPs in positions 74 and 272 (Figure 7(a))The phylogenetic tree of CTX-M-9 gene sequence in Ecoli strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed differentdegrees of dissimilarity between the different strains andmany unique sequences in the Egyptian strain similar tothat of Russia and Australia and dissimilar to that of Japan(Figure 7(b))
4 Discussion
The Gram-negative bacilli are among the most importantcauses of serious nosocomial and community-onset bacte-rial infections in humans and antimicrobial resistance hasbecome a global threat to effective health care delivery [14]However carbapenem-resistant Gram-negative bacilli havebeen increasingly reported worldwide [4] Various acquiredcarbapenemases have been identified in the last years belong-ing to either acquired metallo-beta-lactamases (IMP VIM
Table 2 The distribution of Gram-negative bacilli isolates in eachclinical specimen
Clinical specimens Gram-negative bacilli isolatesType Number Number ()Urine 52 41 788Blood 18 12 666Sputum 29 10 345Pus 9 2 222Total 108 65 (602)1205942= 2128 119875 lt 0001 (statistically significant)
SPM GIM NDM andDIM types) or class A (KPC andGES)and class D 120573-lactamase OXA-48 [15]
In the present study prevalence of 120573-lactamases-producing isolates was found in Table 2 Different studiescarried out by other workers in various parts of the worldshow quite variable results In a study carried out thefrequency of beta-lactamases-producing isolates was urine(61) followed by blood cultures (38) wound swabs (13)and tracheal aspirates (5) (119875 lt 0001) [16] And this issimilar to our study By contrast Shanthi and Sekar [17] inIndia reported that Gram-negative isolates were obtainedfrom the respiratory tract (418) followed by urinary tract
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
International Journal of Microbiology 7
91115115115
205229229229
319343343343
433457457457
547571571571
204228228228
318342342342
432456456456
546570570570
660684684684
Consensus
Consensus
Consensus
Consensus
Consensus
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
AM_372945-25_5-group16-_T-group16-_A041-779
gi|347810717|gb|JN1883661|1-800gi|347810716|gb|JN1883651|1-800gi|675594620|gb|KJ9230021|1-800
(a)
TEM Ecoli Egypt
00041
0002700000
00014
00005
KM5986651gi|675594620|gb|KJ9230021| Escherichia coli strain blaTEM (blaTEM-1) India
gi|383282208|gb|JQ8231751| Escherichia beta-lactamase TEM (blaTEM) India
gi|347810716|gb|JN1883651| Escherichia coli strain ARY 4 blaTEM gene India
(b)115102111111111111111
229216225225225225225
343330339339339339339
228215224224
342329338338338338338
456443452452452452452
224224224
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
AM_372945-26_6-group16-_T-group16-_B041-751
gi|291603834|gb|GU7346961|1-525gi|291603832|gb|GU7346951|1-525gi|291603830|gb|GU7346941|1-525gi|291603822|gb|GU7346901|1-525gi|288190943|gb|GQ4704601|1-525
gi|354805824|gb|JN0433841|1-516
Consensus
Consensus
Consensus
(c)
AM 372945-26 6-group16-T-group16-B04 Kpneumonia Egypt00022
00033
00000
00000
00000
00000
00000
0001500004
00015
00005
00005
KF2683571gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346951| Iran
gi Klebsiella pneumoniae beta-lactamase TEM-1 (blaTem) |GQ4704601| Irangi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |GU7346961| Iran
gi Klebsiella pneumoniae strain TEM-1 (blaTem) gene |GU7346941| Iran
gi Klebsiella pneumoniae strain (blaTem1) gene partial cds |GU7346901| Iran
gi Klebsiella pneumoniae strain (blaTEM1) gene partial cds |JN0433841| India
(d)
Figure 4 The multiple sequences alignments and trees of TEM gene (119887119897119886TEM12) in different bacterial species (a) TEM gene in E coli strainsisolated fromZUHospitals in comparisonwith publishedTEMgene ofE coli strains fromGenBank (b)Aphylogenetic tree of TEMgene ofEcoli isolated fromZUHospitals and published homologous ones inGenBank (c)Themultiple sequences alignments of gene inK pneumoniaestrains isolated from ZU Hospitals in comparison with published TEM gene in K pneumoniae strains from GenBank (d) Phylogenetic treeof sequence of K pneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
8 International Journal of Microbiology
340
340340340340
340340
453
453453453453
453453
566
566566566566
566566
324
324324
211
211211
98
9898
452
452452452452
452452
210
210210
565
565565565
565565
565
323
323323
678
678678678678
678678
436
436436
Consensus
Consensus
Consensus
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
(a)
gi Klebsiella pneumoniae conjugative plasmid beta-lactamase SHV-13 (bla) gene |AF1645771| UK
AM_372945-30 13-group16-T-group16-A04 Ecloacae Egypt
gi Klebsiella pneumoniae beta-lactamase SHV-14 (bla) gene |AF2266221| UK
00000
00022
00087
00022
00000
00000
000000004300000
0002200022
00022
00022
00000
0001
AF1249841
gi Klebsiella pneumoniae extended spectrum beta-lactamase SHV-1 (blaSHV) gene |HM0605401| Iran
gi Klebsiella pneumoniae strain K16R SHV-1 beta-lactamase (blaSHV) gene |HM7511021| Brazil
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-11 (blaSHV) |GQ4704281| Iran
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-1 (blaSHV) |HM0605381| Iran
gi Klebsiella pneumoniae plasmid blaSHV gene for beta-lactamase SHV |AB6757231| Japan
gi Klebsiella pneumoniae blaSHV type 1 gene complete cds|DQ3557841| Brazil
gi Klebsiella pneumoniae blaSHV gene for beta-lactamase class A |Y110691| France
(b)
Figure 5Themultiple sequences alignments and trees of SHV gene in different species (a) SHV gene inK pneumoniae strains isolated fromZUHospitals in comparison with published SHV gene of K pneumoniae strains from GenBank (b) Phylogenetic tree of SHV sequence of Kpneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
sequence of E coli isolated fromZagazig University Hospitalsand published homologous ones in GenBank showed dissim-ilarity degree between Egyptian and other universal strains(Figure 6(b))
(2) CTX-M-1 Gene (blaCTX-M-1) of Klebsiella pneumoniaeStrains The alignment in this case showed 39 differentcommon SNPs between the different strains The SNPspositions were indicated in positions 1 rarr 39 (Figure 6(c))A phylogenetic tree of CTX-M-1 gene sequence in K pneu-moniae strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed different degrees
of dissimilarity between the different strains with manyunique sequences in Egyptian strain (Figure 6(d))
(3) CTX-M-1 Gene (blaCTX-M-1) of Pseudomonas aeruginosaStrainsTheCTX-M-1 gene isolated fromP aeruginosa strainsin Zagazig University Hospitals was compared using BLASTprogram with published CTX-M-1 gene in P aeruginosastrains from GenBank (eg Paeruginosa KC5712551) Theresults showed 4 different common SNPs between the differ-ent strainsThe SNPs positions were indicated in 117 206 228and 283 (Figure 6(e)) A phylogenetic tree showed similaritydegree between Egyptian and Russian strains (Figure 6(f))
International Journal of Microbiology 9
601601601601
629688688688
Consensus
CTX11-629gi|695214033|ref|NG_0367291|1-688gi|224696954|emb|FM2133711|1-688gi|402795953|dbj|AB7015731|1-688
(a)
CTX1 Ecoli Egypt05168
00000
00000
0000005168
01
AP0146461
gi |NG 0367291| Escherichia coli blaCTX-M-3 gene for beta-lactamase USA
gi Escherichia coli DNA ISEcp1-blaCTX-M-15 |AB7015731| Japan
gi Escherichia coli blaCTX-M-3 gene for beta-lactamase |FM2133711| Poland
(b)227
2911
340142
3391417474
452254187187
7575
Consensus
Consensus
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
(c)
gi Klebsiella pneumoniae strain 285L extended spectrum beta-lactamase CTX-M-15 |GQ4704351|Iran
CTX1 Klebsiella pneumoniae Egyptgi Klebsiella pneumoniae strain 212L extended spectrum beta-lactamase CTX-M-15 |GQ4704311| Irangi Klebsiella pneumoniae CTX-M-15|GQ8655681| India
00000
0000000000
07585
07515
00070
02
KJ4514101
gi Klebsiella pneumoniae (blaCTX-M-15) gene |EU5567551|Hungary
(d)56
113113
167224224
279336336
391448448
168225225
280337337
Consensus
Consensus
Consensus
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
(e)
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia(2)CTX1 Pseudomonas aeruginosa Egypt00024
00000
0000000024
00005
KC5712551
(f)
Figure 6 The multiple sequences alignments and trees of CTX-M-1 gene in different species (a) CTX-M-1 gene in E coli strains isolatedfrom ZU Hospitals in comparison with published CTX-M-1 gene of E coli strains from GenBank (b) A tree of CTX-M-1 sequence of E coliisolated from ZUHospitals and published homologs in GenBank (c)Themultiple sequences alignments of CTX-M-1 gene in K pneumoniaestrains isolated from ZU Hospitals in comparison with published CTX-M-1 gene in K pneumoniae strains from GenBank (d) Phylogenetictree of CTX-M-1 sequence of K pneumoniae isolated from ZU Hospitals and published homologous sequences in GenBank (e) Multiplesequences alignments of CTX-M-1 gene in P aeruginosa strains isolated from ZU Hospitals in comparison with published CTX-M-1 gene inP aeruginosa strains from GenBank (f) Phylogenetic tree of CTX-M-1 sequence of P aeruginosa isolated from ZU Hospitals and publishedhomologs in GenBank
10 International Journal of Microbiology
11111
113113113113113
225225225225225
Consensus
Consensus
Consensus
112112112112112
224224224224224
336336336336336
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
(a)
00000
00000
00037
00037
00005
JN6768431
AM 372945-35 21-group16- g9-group16- C05 (830bp) Ecoli Egypt
gi Escherichia coli (blaCTX-M-9b) gene complete cds |EU4189151|Australia
gi Escherichia coli strain K-340 (blaCTX-M-9) gene complete cds |HM5697351|Russia
gi Escherichia coli DNA blaCTX-M-14 gene |AB9765961|Japan
(b)
Figure 7Themultiple sequences alignments and tree of CTX-M-9 gene in different species (a) CTX-M-9 gene in E coli strains isolated fromZU Hospitals in comparison with published CTX-M-9 gene of E coli strains from GenBank (b) Phylogenetic tree of CTX-M-9 sequence ofE coli isolated from ZU Hospitals and published homologous ones in GenBank
345 The Analysis of CTX-M-9 Gene (119887119897119886CTX-M-9) inEscherichia coli Strains The CTX-M-9 gene isolated fromE coli strains in Zagazig University Hospitals was comparedwith published CTX-M-1 gene in P aeruginosa strains fromGenBank using BLAST program (eg E coli JN6768431)The multiple sequences alignments showed 2 differentcommon SNPs in positions 74 and 272 (Figure 7(a))The phylogenetic tree of CTX-M-9 gene sequence in Ecoli strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed differentdegrees of dissimilarity between the different strains andmany unique sequences in the Egyptian strain similar tothat of Russia and Australia and dissimilar to that of Japan(Figure 7(b))
4 Discussion
The Gram-negative bacilli are among the most importantcauses of serious nosocomial and community-onset bacte-rial infections in humans and antimicrobial resistance hasbecome a global threat to effective health care delivery [14]However carbapenem-resistant Gram-negative bacilli havebeen increasingly reported worldwide [4] Various acquiredcarbapenemases have been identified in the last years belong-ing to either acquired metallo-beta-lactamases (IMP VIM
Table 2 The distribution of Gram-negative bacilli isolates in eachclinical specimen
Clinical specimens Gram-negative bacilli isolatesType Number Number ()Urine 52 41 788Blood 18 12 666Sputum 29 10 345Pus 9 2 222Total 108 65 (602)1205942= 2128 119875 lt 0001 (statistically significant)
SPM GIM NDM andDIM types) or class A (KPC andGES)and class D 120573-lactamase OXA-48 [15]
In the present study prevalence of 120573-lactamases-producing isolates was found in Table 2 Different studiescarried out by other workers in various parts of the worldshow quite variable results In a study carried out thefrequency of beta-lactamases-producing isolates was urine(61) followed by blood cultures (38) wound swabs (13)and tracheal aspirates (5) (119875 lt 0001) [16] And this issimilar to our study By contrast Shanthi and Sekar [17] inIndia reported that Gram-negative isolates were obtainedfrom the respiratory tract (418) followed by urinary tract
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
8 International Journal of Microbiology
340
340340340340
340340
453
453453453453
453453
566
566566566566
566566
324
324324
211
211211
98
9898
452
452452452452
452452
210
210210
565
565565565
565565
565
323
323323
678
678678678678
678678
436
436436
Consensus
Consensus
Consensus
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
AM_372945-30_13-group16-_T-group16-_A041-713gi|295414017|gb|HM0605401|1-470
gi|295414013|gb|HM0605381|1-470gi|313766531|gb|HM7511021|1-713gi|86278447|gb|DQ3557841|1-713
gi|5457153|gb|AF1645771|1-713gi|10443723|gb|AF2266221|1-713
gi|1841439|emb|Y110691|1-713gi|283490011|gb|GQ4704281|1-470
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
gi|370981682|dbj|AB6757231|1-706
(a)
gi Klebsiella pneumoniae conjugative plasmid beta-lactamase SHV-13 (bla) gene |AF1645771| UK
AM_372945-30 13-group16-T-group16-A04 Ecloacae Egypt
gi Klebsiella pneumoniae beta-lactamase SHV-14 (bla) gene |AF2266221| UK
00000
00022
00087
00022
00000
00000
000000004300000
0002200022
00022
00022
00000
0001
AF1249841
gi Klebsiella pneumoniae extended spectrum beta-lactamase SHV-1 (blaSHV) gene |HM0605401| Iran
gi Klebsiella pneumoniae strain K16R SHV-1 beta-lactamase (blaSHV) gene |HM7511021| Brazil
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-11 (blaSHV) |GQ4704281| Iran
gi Klebsiella pneumoniae strain extended spectrum beta-lactamase SHV-1 (blaSHV) |HM0605381| Iran
gi Klebsiella pneumoniae plasmid blaSHV gene for beta-lactamase SHV |AB6757231| Japan
gi Klebsiella pneumoniae blaSHV type 1 gene complete cds|DQ3557841| Brazil
gi Klebsiella pneumoniae blaSHV gene for beta-lactamase class A |Y110691| France
(b)
Figure 5Themultiple sequences alignments and trees of SHV gene in different species (a) SHV gene inK pneumoniae strains isolated fromZUHospitals in comparison with published SHV gene of K pneumoniae strains from GenBank (b) Phylogenetic tree of SHV sequence of Kpneumoniae isolated from ZU Hospitals and published homologous ones in GenBank
sequence of E coli isolated fromZagazig University Hospitalsand published homologous ones in GenBank showed dissim-ilarity degree between Egyptian and other universal strains(Figure 6(b))
(2) CTX-M-1 Gene (blaCTX-M-1) of Klebsiella pneumoniaeStrains The alignment in this case showed 39 differentcommon SNPs between the different strains The SNPspositions were indicated in positions 1 rarr 39 (Figure 6(c))A phylogenetic tree of CTX-M-1 gene sequence in K pneu-moniae strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed different degrees
of dissimilarity between the different strains with manyunique sequences in Egyptian strain (Figure 6(d))
(3) CTX-M-1 Gene (blaCTX-M-1) of Pseudomonas aeruginosaStrainsTheCTX-M-1 gene isolated fromP aeruginosa strainsin Zagazig University Hospitals was compared using BLASTprogram with published CTX-M-1 gene in P aeruginosastrains from GenBank (eg Paeruginosa KC5712551) Theresults showed 4 different common SNPs between the differ-ent strainsThe SNPs positions were indicated in 117 206 228and 283 (Figure 6(e)) A phylogenetic tree showed similaritydegree between Egyptian and Russian strains (Figure 6(f))
International Journal of Microbiology 9
601601601601
629688688688
Consensus
CTX11-629gi|695214033|ref|NG_0367291|1-688gi|224696954|emb|FM2133711|1-688gi|402795953|dbj|AB7015731|1-688
(a)
CTX1 Ecoli Egypt05168
00000
00000
0000005168
01
AP0146461
gi |NG 0367291| Escherichia coli blaCTX-M-3 gene for beta-lactamase USA
gi Escherichia coli DNA ISEcp1-blaCTX-M-15 |AB7015731| Japan
gi Escherichia coli blaCTX-M-3 gene for beta-lactamase |FM2133711| Poland
(b)227
2911
340142
3391417474
452254187187
7575
Consensus
Consensus
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
(c)
gi Klebsiella pneumoniae strain 285L extended spectrum beta-lactamase CTX-M-15 |GQ4704351|Iran
CTX1 Klebsiella pneumoniae Egyptgi Klebsiella pneumoniae strain 212L extended spectrum beta-lactamase CTX-M-15 |GQ4704311| Irangi Klebsiella pneumoniae CTX-M-15|GQ8655681| India
00000
0000000000
07585
07515
00070
02
KJ4514101
gi Klebsiella pneumoniae (blaCTX-M-15) gene |EU5567551|Hungary
(d)56
113113
167224224
279336336
391448448
168225225
280337337
Consensus
Consensus
Consensus
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
(e)
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia(2)CTX1 Pseudomonas aeruginosa Egypt00024
00000
0000000024
00005
KC5712551
(f)
Figure 6 The multiple sequences alignments and trees of CTX-M-1 gene in different species (a) CTX-M-1 gene in E coli strains isolatedfrom ZU Hospitals in comparison with published CTX-M-1 gene of E coli strains from GenBank (b) A tree of CTX-M-1 sequence of E coliisolated from ZUHospitals and published homologs in GenBank (c)Themultiple sequences alignments of CTX-M-1 gene in K pneumoniaestrains isolated from ZU Hospitals in comparison with published CTX-M-1 gene in K pneumoniae strains from GenBank (d) Phylogenetictree of CTX-M-1 sequence of K pneumoniae isolated from ZU Hospitals and published homologous sequences in GenBank (e) Multiplesequences alignments of CTX-M-1 gene in P aeruginosa strains isolated from ZU Hospitals in comparison with published CTX-M-1 gene inP aeruginosa strains from GenBank (f) Phylogenetic tree of CTX-M-1 sequence of P aeruginosa isolated from ZU Hospitals and publishedhomologs in GenBank
10 International Journal of Microbiology
11111
113113113113113
225225225225225
Consensus
Consensus
Consensus
112112112112112
224224224224224
336336336336336
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
(a)
00000
00000
00037
00037
00005
JN6768431
AM 372945-35 21-group16- g9-group16- C05 (830bp) Ecoli Egypt
gi Escherichia coli (blaCTX-M-9b) gene complete cds |EU4189151|Australia
gi Escherichia coli strain K-340 (blaCTX-M-9) gene complete cds |HM5697351|Russia
gi Escherichia coli DNA blaCTX-M-14 gene |AB9765961|Japan
(b)
Figure 7Themultiple sequences alignments and tree of CTX-M-9 gene in different species (a) CTX-M-9 gene in E coli strains isolated fromZU Hospitals in comparison with published CTX-M-9 gene of E coli strains from GenBank (b) Phylogenetic tree of CTX-M-9 sequence ofE coli isolated from ZU Hospitals and published homologous ones in GenBank
345 The Analysis of CTX-M-9 Gene (119887119897119886CTX-M-9) inEscherichia coli Strains The CTX-M-9 gene isolated fromE coli strains in Zagazig University Hospitals was comparedwith published CTX-M-1 gene in P aeruginosa strains fromGenBank using BLAST program (eg E coli JN6768431)The multiple sequences alignments showed 2 differentcommon SNPs in positions 74 and 272 (Figure 7(a))The phylogenetic tree of CTX-M-9 gene sequence in Ecoli strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed differentdegrees of dissimilarity between the different strains andmany unique sequences in the Egyptian strain similar tothat of Russia and Australia and dissimilar to that of Japan(Figure 7(b))
4 Discussion
The Gram-negative bacilli are among the most importantcauses of serious nosocomial and community-onset bacte-rial infections in humans and antimicrobial resistance hasbecome a global threat to effective health care delivery [14]However carbapenem-resistant Gram-negative bacilli havebeen increasingly reported worldwide [4] Various acquiredcarbapenemases have been identified in the last years belong-ing to either acquired metallo-beta-lactamases (IMP VIM
Table 2 The distribution of Gram-negative bacilli isolates in eachclinical specimen
Clinical specimens Gram-negative bacilli isolatesType Number Number ()Urine 52 41 788Blood 18 12 666Sputum 29 10 345Pus 9 2 222Total 108 65 (602)1205942= 2128 119875 lt 0001 (statistically significant)
SPM GIM NDM andDIM types) or class A (KPC andGES)and class D 120573-lactamase OXA-48 [15]
In the present study prevalence of 120573-lactamases-producing isolates was found in Table 2 Different studiescarried out by other workers in various parts of the worldshow quite variable results In a study carried out thefrequency of beta-lactamases-producing isolates was urine(61) followed by blood cultures (38) wound swabs (13)and tracheal aspirates (5) (119875 lt 0001) [16] And this issimilar to our study By contrast Shanthi and Sekar [17] inIndia reported that Gram-negative isolates were obtainedfrom the respiratory tract (418) followed by urinary tract
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
International Journal of Microbiology 9
601601601601
629688688688
Consensus
CTX11-629gi|695214033|ref|NG_0367291|1-688gi|224696954|emb|FM2133711|1-688gi|402795953|dbj|AB7015731|1-688
(a)
CTX1 Ecoli Egypt05168
00000
00000
0000005168
01
AP0146461
gi |NG 0367291| Escherichia coli blaCTX-M-3 gene for beta-lactamase USA
gi Escherichia coli DNA ISEcp1-blaCTX-M-15 |AB7015731| Japan
gi Escherichia coli blaCTX-M-3 gene for beta-lactamase |FM2133711| Poland
(b)227
2911
340142
3391417474
452254187187
7575
Consensus
Consensus
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
gi|288190909|gb|GQ4704431|1-496gi|288190907|gb|GQ4704421|1-429gi|288190905|gb|GQ4704411|1-429
AM_372945-30_15-group16-_g1-group16-_F041-497
(c)
gi Klebsiella pneumoniae strain 285L extended spectrum beta-lactamase CTX-M-15 |GQ4704351|Iran
CTX1 Klebsiella pneumoniae Egyptgi Klebsiella pneumoniae strain 212L extended spectrum beta-lactamase CTX-M-15 |GQ4704311| Irangi Klebsiella pneumoniae CTX-M-15|GQ8655681| India
00000
0000000000
07585
07515
00070
02
KJ4514101
gi Klebsiella pneumoniae (blaCTX-M-15) gene |EU5567551|Hungary
(d)56
113113
167224224
279336336
391448448
168225225
280337337
Consensus
Consensus
Consensus
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
gi|584111314|gb|KF8761331|1-607gi|584111414|gb|KF8771341|_1-607
AM_372945-31_16-group16-_g1-group16-_G041-633
(e)
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia
gi|584111314|gb|KF8761331| Pseudomonas aeruginosa strain B-757P Russia(2)CTX1 Pseudomonas aeruginosa Egypt00024
00000
0000000024
00005
KC5712551
(f)
Figure 6 The multiple sequences alignments and trees of CTX-M-1 gene in different species (a) CTX-M-1 gene in E coli strains isolatedfrom ZU Hospitals in comparison with published CTX-M-1 gene of E coli strains from GenBank (b) A tree of CTX-M-1 sequence of E coliisolated from ZUHospitals and published homologs in GenBank (c)Themultiple sequences alignments of CTX-M-1 gene in K pneumoniaestrains isolated from ZU Hospitals in comparison with published CTX-M-1 gene in K pneumoniae strains from GenBank (d) Phylogenetictree of CTX-M-1 sequence of K pneumoniae isolated from ZU Hospitals and published homologous sequences in GenBank (e) Multiplesequences alignments of CTX-M-1 gene in P aeruginosa strains isolated from ZU Hospitals in comparison with published CTX-M-1 gene inP aeruginosa strains from GenBank (f) Phylogenetic tree of CTX-M-1 sequence of P aeruginosa isolated from ZU Hospitals and publishedhomologs in GenBank
10 International Journal of Microbiology
11111
113113113113113
225225225225225
Consensus
Consensus
Consensus
112112112112112
224224224224224
336336336336336
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
(a)
00000
00000
00037
00037
00005
JN6768431
AM 372945-35 21-group16- g9-group16- C05 (830bp) Ecoli Egypt
gi Escherichia coli (blaCTX-M-9b) gene complete cds |EU4189151|Australia
gi Escherichia coli strain K-340 (blaCTX-M-9) gene complete cds |HM5697351|Russia
gi Escherichia coli DNA blaCTX-M-14 gene |AB9765961|Japan
(b)
Figure 7Themultiple sequences alignments and tree of CTX-M-9 gene in different species (a) CTX-M-9 gene in E coli strains isolated fromZU Hospitals in comparison with published CTX-M-9 gene of E coli strains from GenBank (b) Phylogenetic tree of CTX-M-9 sequence ofE coli isolated from ZU Hospitals and published homologous ones in GenBank
345 The Analysis of CTX-M-9 Gene (119887119897119886CTX-M-9) inEscherichia coli Strains The CTX-M-9 gene isolated fromE coli strains in Zagazig University Hospitals was comparedwith published CTX-M-1 gene in P aeruginosa strains fromGenBank using BLAST program (eg E coli JN6768431)The multiple sequences alignments showed 2 differentcommon SNPs in positions 74 and 272 (Figure 7(a))The phylogenetic tree of CTX-M-9 gene sequence in Ecoli strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed differentdegrees of dissimilarity between the different strains andmany unique sequences in the Egyptian strain similar tothat of Russia and Australia and dissimilar to that of Japan(Figure 7(b))
4 Discussion
The Gram-negative bacilli are among the most importantcauses of serious nosocomial and community-onset bacte-rial infections in humans and antimicrobial resistance hasbecome a global threat to effective health care delivery [14]However carbapenem-resistant Gram-negative bacilli havebeen increasingly reported worldwide [4] Various acquiredcarbapenemases have been identified in the last years belong-ing to either acquired metallo-beta-lactamases (IMP VIM
Table 2 The distribution of Gram-negative bacilli isolates in eachclinical specimen
Clinical specimens Gram-negative bacilli isolatesType Number Number ()Urine 52 41 788Blood 18 12 666Sputum 29 10 345Pus 9 2 222Total 108 65 (602)1205942= 2128 119875 lt 0001 (statistically significant)
SPM GIM NDM andDIM types) or class A (KPC andGES)and class D 120573-lactamase OXA-48 [15]
In the present study prevalence of 120573-lactamases-producing isolates was found in Table 2 Different studiescarried out by other workers in various parts of the worldshow quite variable results In a study carried out thefrequency of beta-lactamases-producing isolates was urine(61) followed by blood cultures (38) wound swabs (13)and tracheal aspirates (5) (119875 lt 0001) [16] And this issimilar to our study By contrast Shanthi and Sekar [17] inIndia reported that Gram-negative isolates were obtainedfrom the respiratory tract (418) followed by urinary tract
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
10 International Journal of Microbiology
11111
113113113113113
225225225225225
Consensus
Consensus
Consensus
112112112112112
224224224224224
336336336336336
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
gi|221149276|gb|EU4189151|1-561gi|295917909|gb|GU7328351|1-561gi|668347703|dbj|AB9765961|1-561gi|299483205|gb|HM5697351|1-561
AM_372945-35_21-group16-_g9-group16-_C051-552
(a)
00000
00000
00037
00037
00005
JN6768431
AM 372945-35 21-group16- g9-group16- C05 (830bp) Ecoli Egypt
gi Escherichia coli (blaCTX-M-9b) gene complete cds |EU4189151|Australia
gi Escherichia coli strain K-340 (blaCTX-M-9) gene complete cds |HM5697351|Russia
gi Escherichia coli DNA blaCTX-M-14 gene |AB9765961|Japan
(b)
Figure 7Themultiple sequences alignments and tree of CTX-M-9 gene in different species (a) CTX-M-9 gene in E coli strains isolated fromZU Hospitals in comparison with published CTX-M-9 gene of E coli strains from GenBank (b) Phylogenetic tree of CTX-M-9 sequence ofE coli isolated from ZU Hospitals and published homologous ones in GenBank
345 The Analysis of CTX-M-9 Gene (119887119897119886CTX-M-9) inEscherichia coli Strains The CTX-M-9 gene isolated fromE coli strains in Zagazig University Hospitals was comparedwith published CTX-M-1 gene in P aeruginosa strains fromGenBank using BLAST program (eg E coli JN6768431)The multiple sequences alignments showed 2 differentcommon SNPs in positions 74 and 272 (Figure 7(a))The phylogenetic tree of CTX-M-9 gene sequence in Ecoli strains isolated from ZU Hospitals and publishedhomologous sequences in GenBank showed differentdegrees of dissimilarity between the different strains andmany unique sequences in the Egyptian strain similar tothat of Russia and Australia and dissimilar to that of Japan(Figure 7(b))
4 Discussion
The Gram-negative bacilli are among the most importantcauses of serious nosocomial and community-onset bacte-rial infections in humans and antimicrobial resistance hasbecome a global threat to effective health care delivery [14]However carbapenem-resistant Gram-negative bacilli havebeen increasingly reported worldwide [4] Various acquiredcarbapenemases have been identified in the last years belong-ing to either acquired metallo-beta-lactamases (IMP VIM
Table 2 The distribution of Gram-negative bacilli isolates in eachclinical specimen
Clinical specimens Gram-negative bacilli isolatesType Number Number ()Urine 52 41 788Blood 18 12 666Sputum 29 10 345Pus 9 2 222Total 108 65 (602)1205942= 2128 119875 lt 0001 (statistically significant)
SPM GIM NDM andDIM types) or class A (KPC andGES)and class D 120573-lactamase OXA-48 [15]
In the present study prevalence of 120573-lactamases-producing isolates was found in Table 2 Different studiescarried out by other workers in various parts of the worldshow quite variable results In a study carried out thefrequency of beta-lactamases-producing isolates was urine(61) followed by blood cultures (38) wound swabs (13)and tracheal aspirates (5) (119875 lt 0001) [16] And this issimilar to our study By contrast Shanthi and Sekar [17] inIndia reported that Gram-negative isolates were obtainedfrom the respiratory tract (418) followed by urinary tract
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
International Journal of Microbiology 11
Table 3 API 20E identification of Gram-negative bacilli isolatesamong positive clinical specimens
Organism Total = 65Number ()
Escherichia coli 30 461Klebsiella pneumoniae 17 262Enterobacter cloacae 4 61Pseudomonas aeruginosa 7 107Proteus mirabilis 2 307Acinetobacter baumanii 3 46Citrobacter freundii 1 15Proteus vulgaris 1 15119875 lt 0001 (statistically significant)
(255) wound (20) and blood (127) Also pus wasthe most common specimen accounting for 21 followedby tracheal aspirate (17) sputum (16) urine (11) andblood (7) [18]
Various risk factors of 120573-lactamases have been implicatedin selection and spread producing strains from variousclinical samples
In accordance with distribution of Gram-negative bacilli(461) Escherichia coli and (262) Klebsiella pneumoniaeisolates followed by (107) P aeruginosa were identifiedas the commonest isolates among Gram-negative bacilli(Table 3) and this coincidedwith that concluded by Sahu et al[19]who found that 58were identified asEscherichia coli fol-lowed by 277 Klebsiella pneumoniae and 15 Pseudomonasaeruginosa in Udaipur Rajasthan In a study by Vipin etal [20] 52 (5842) isolates of Escherichia coli were foundto be the most common organisms in Allahabad followedby Klebsiella pneumoniae (2022) Pseudomonas aerugi-nosa (1235) Proteus vulgaris (337) Proteus mirabilis(224) and Enterobacter cloacae (224) Also in IndiaSankarankutty and Kaup [21] documented the same resultin that 5842 isolates of Escherichia coli were found to bethe most common organisms followed by Klebsiella pneu-moniae (2022) Pseudomonas aeruginosa (1235) Proteusvulgaris (337) Proteus mirabilis (224) and Enterobacteraerogenes (224)
But our study disagreed with that published by Aboderinet al [22] who reported that Pseudomonas aeruginosarecorded the highest prevalence followed by Klebsiella pneu-moniae and ESBL producers whereas frequency among Ecoli isolates was much lower than Klebsiella pneumoniaeHence prevalence of pathogens often varies dramaticallybetween communities according to geography hospitals inthe same community and among different patient popula-tions in the same hospital
In this study risk factors associated with isolation ofGram-negative bacilli isolates were shown in Table 4 Andthis was matched with that reported by Kumar et al [23] whoexhibitedmajor risk factors such as prolonged hospitalizationgt 8 days previous antibiotic use trauma and mechanicalventilation which may contribute to the mortality
In Turkey Aktas et al [24] reported risk factors foracquisition including prolonged hospitalization an ICU stayventilator usage previous use of carbapenem antibiotics andthe presence of underlying diseases and this is compatiblewith our research But in Brazil Tuon et al [25] documentedthat there was statistical significance in isolation of Klebsiellapneumoniae isolates according to age (119875 = 0005) andmechanical ventilation (119875 = 0003) while trauma (119875 = 087)and ICU stay (119875 = 025) had a statistical significance asmajorrisk factors
The importance of these risk factors lies in the epidemi-ological implications at the hospital level because the resultssuggest a probable nosocomial transmission of the infection
Resistance pattern among nosocomial bacterialpathogens may vary widely from country to country atany time and within the same country over time [26]
In our study all the isolates were resistant to cefotaxime(100) and displayed unusually high level of imipenem-resistance (508) isolates with MICs ranging from 156 to250 120583gmL (Table 5) (119875 lt 0001) In Egypt this was parallelto that reported by Mohamed and Raafat [27] who reported(522) imipenem-resistance among isolates (100) cefo-taxime resistance (55) susceptible-ciprofloxacin and (70)susceptibility to amikacin In theMiddle East the occurrenceof imipenem-resistant Gram-negative bacilli is alarminglyelevated Another similar study showed that all 84 Klebsiellapneumoniae isolates exhibited resistance to imipenem withMICs ranging from 4 to gt32 120583gmL in a Greek hospital [28]
Another dissimilar study was shown in Saudi Arabiawhere the susceptibility rate of Gram-negative organismsisolated from a tertiary care hospital to imipenem wasreported to be as low as 10 [29] Galani et al [30] reportedthat Klebsiella pneumoniae and Escherichia coli isolates werefound to be susceptible to imipenem in routine suscep-tibility disk diffusion tests Other authors observed thatall beta-lactamases producers of Escherichia coli Klebsiellapneumoniae and Pseudomonas aeruginosa were suscepti-ble to imipenem showing coresistance to other antibioticsof aminoglycosides fluoroquinolones and others [17] Theextensive use of carbapenems in some locations has likelycreated a selective antibiotic pressure which in turn hasresulted in an increased prevalence of carbapenem-resistantGram-negative isolates
The carbapenem resistance due to production of 120573-lactamases has a potential for rapid dissemination since it isoften plasmid-mediated [2] Consequently rapid detection of120573-lactamases is necessary to initiate effective infection con-trol measures to prevent their uncontrolled spread in clinicalsettings In Egyptian hospitals the 120573-lactamases presence wasconfirmed by PCR amplification
In our study the percentage of 119887119897119886VIM 119887119897119886TEM 119887119897119886SHVand 119887119897119886CTX-M genes among Gram-negative bacilli isolateswas shown in Table 6 As regards 119887119897119886VIM gene detectedin our results it is similar to that 119887119897119886VIM gene encodingMBL among the isolates of P aeruginosa (613) in Tehranhospitals [31] On the contrary 119887119897119886VIM genes were notdetected among the studied Gram-negative isolates in otherTehran hospitals [32] TEM SHV and CTX-M genes are themost common plasmid-mediated lactamases often found in
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
12 International Journal of Microbiology
Table 4 Risk factors associated with isolation of Gram-negative bacilli isolates
Risk factor Gram-negativebacilli isolates
Total number ofsamples Relative risk (95 CI)lowast 119875 value significance
Agelt40 26 45 107 (078ndash147) 066gt40 39 63
SexMale 29 49 109 (08ndash147) 059Female 36 59
TraumaYes 48 59 234 (157ndash351) lt0001No 17 49
Hospitalization length other than ICUlt7 days 15 51 298 (133ndash461) lt0001gt7 days 50 57
ICU admissionYes 28 46 102 (045ndash247) lt0001No 37 62
Urinary catheterYes 18 32 091 (064ndash129) 058No 47 76
Ventilator supportYes 10 18 083 (051ndash135) 044No 20 30
Central venous catheterYes 4 9 067 (031ndash143) 026No 26 39lowast = 95 confidence interval
Table 5 Antimicrobial susceptibility patterns by disc diffusion method
AntibioticAntimicrobial susceptibility patterns of all Gram-negative bacilli isolates
Susceptible Intermediate ResistantNumber () Number () Number ()
Imipenem 31 477 1 15 33 508Amikacin 40 lowast615 1 15 24 446Ciprofloxacin 35 538 3 46 27 415Piperacillin 15 231 6 lowast92 44 677Cefoperazonesulbactam 21 323 4 61 40 615Cefoxitin 12 184 0 000 53 815Cefotaxime 0 000 0 000 65 lowast10000lowast119875 lt 0001 (statistically significant)
Enterobacteriaceae and P aeruginosa [33] In Iran Eftekharet al [34] showed 693 119887119897119886TEM and 3137 119887119897119886CTX-M-1 genesamongGram-negative isolates and this agreedwith our studyAlso presence of 119887119897119886CTX-M19 119886SHV and 119887119897119886TEM genes amongtested rods of the Enterobacteriaceae family was revealed byOjdana et al [35] Another study reported by Cuzon et al[36] harbored similar results regarding carbapenem-resistantGram-negative isolates carrying TEM SHV CTX-M-1 andCTX-M-9 genes
In Switzerland Zurfluh et al [37] mentioned that theisolates of Enterobacteriaceae were further screened for blagenes encoding SHV TEM CTX-M group 1 CTX-M group2 or CTX-M group 9 enzymes with (23) (713) (392)(201) and (156) respectively
Other authors noted different observations in that clinicalisolates of Escherichia coli and Pseudomonas aeruginosacarried 119887119897119886CTX-M-types which was the most common (958)followed by 119887119897119886TEM (292) 119887119897119886SHV (73) and 119887119897119886VIM
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
International Journal of Microbiology 13
Table 6 The percentage of blaVIM blaTEM blaSHV and blaCTX-M genes among Gram-negative bacilli isolates
Isolates 120573-lactamases genes
Organism Number VIM TEM SHV CTX-M-1 CTX-M-9 CTX-M-825Number () Number () Number () Number () Number () Number ()
Escherichia coli 15 10 666 13 870 0 00 3 200 4 266 0 000Klebsiella pneumonia 10 8 800 9 900 5 50 6 600 1 100 0 000Enterobacter cloaca 2 1 500 1 500 0 00 0 000 0 000 0 000Pseudomonas aeruginosa 4 2 500 1 250 0 00 3 750 1 250 0 000Proteus mirabilis 1 0 000 0 000 0 00 0 000 0 000 0 000Acinetobacter baumanii 1 1 100 0 000 0 00 0 000 0 000 0 000Total 33 22 667 24 727 5 150 12 360 6 182 0 000
(125) in Nepal [38] These observations contribute to theknowledge of the epidemiology of VIM TEM SHV andCTX-M-producing Gram-negative isolates that have nowbecome endemic in major hospitals in Egypt Continuousmonitoring proper infection control and surveillance andprevention practices will limit the further spread of theseinfections within these hospitals and clinical settings
Multiple sequences analysis is used in such biologicalstudies to extract important phylogenetic and evolutionaryinformation using different scoringmatrices (BLOSUM62 forBLAST BLOSUM50 for SEARCH and FASTA) [39]
5 Conclusion
There is a high prevalence of120573-lactamase genes in our clinicalisolates that are responsible for such resistance Hence itis essential to report 120573-lactamases production along withroutine sensitivity reports which will help the clinician inprescribing proper antibiotics Also the sequence analysis ofamplified genes showed differences between multiple SNPsin the same gene among different local isolates and withinternationally published sequences In the end it has beenfelt that there is a need to formulate strategies to detect andprevent the emergence of 120573-lactamases producing strains forthe effective treatment of infections which are caused bythem
Conflict of Interests
The authors have declared no conflict of interests and theyhave no financial conflicts
Acknowledgments
The authors would like to express their sincere thanksand deepest gratitude to Professor Dr Ahmed Mansour AlZohairy Assistant Professor of genetics Faculty of Agri-culture Zagazig University for his help in achieving andplanning bioinformatics of sequences
References
[1] J Breslow ldquoIllinois lsquoNightmare Bacteriarsquo Outbreak RaisesAlarmsrdquo April 2014 httpwwwpbsorg
[2] HM ZowawiHH Balkhy T RWalsh andD L Paterson ldquo120573-Lactamase production in key gram-negative pathogen isolatesfrom theArabian PeninsulardquoClinicalMicrobiology Reviews vol26 no 3 pp 361ndash380 2013
[3] J N Kattan M V Villegas and J P Quinn ldquoNew developmentsin carbapenemsrdquoClinicalMicrobiology and Infection vol 14 no12 pp 1102ndash1111 2008
[4] K M Papp-Wallace A Endimiani M A Taracila and R ABonomo ldquoCarbapenems past present and futurerdquo Antimicro-bial Agents and Chemotherapy vol 55 no 11 pp 4943ndash49602011
[5] H Lee K S Ko J-H Song and K R Peck ldquoAntimicrobialactivity of doripenem and other carbapenems against gram-negative pathogens fromKoreardquoMicrobial Drug Resistance vol17 no 1 pp 37ndash45 2011
[6] M A Toleman and T R Walsh ldquoEvolution of the ISCR3 groupof ISCR elementsrdquoAntimicrobial Agents and Chemotherapy vol52 no 10 pp 3789ndash3791 2008
[7] S A Jemima and S Verghese ldquoMultiplex PCR for 119887119897119886CTX-Mand 119887119897119886SHV in the extended spectrum-B-lactamase (ESBL) pro-ducing gram-negative isolatesrdquo The Indian Journal of MedicalResearch vol 128 no 3 pp 313ndash317 2008
[8] R C Picao L Poirel A C Gales and P Nordmann ldquoDiver-sity of 120573-lactamases produced by ceftazidime-resistant Pseu-domonas aeruginosa isolates causing bloodstream infections inBrazilrdquo Antimicrobial Agents and Chemotherapy vol 53 no 9pp 3908ndash3913 2009
[9] E SMoland J A Black J OuradaMD ReisbigNDHansonandK SThomson ldquoOccurrence of newer120573-lactamases inKleb-siella pneumoniae isolates from24USHospitalsrdquoAntimicrobialAgents and Chemotherapy vol 46 no 12 pp 3837ndash3842 2002
[10] L K Dianna and H G Peter ldquoPseudomonasrdquo in Manual ofClinical Microbiology R M Patrick J B Ellen H J James A PMiccael and H Y Robert Eds vol 1 pp 719ndash728 ASM PressWashington DC USA 8th edition 2003
[11] Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing Twenty-SecondInformational Supplement CLSI M100-S22 Clinical and Labo-ratory Standards Institute Wayne Pa USA 2012
[12] C Dallenne A da Costa D Decre C Favier and G ArletldquoDevelopment of a set of multiplex PCR assays for the detection
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
14 International Journal of Microbiology
of genes encoding important 120573-lactamases in Enterobacteri-aceaerdquo Journal of Antimicrobial Chemotherapy vol 65 no 3Article ID dkp498 pp 490ndash495 2010
[13] S F AltschulW GishWMiller EWMyers and D J LipmanldquoBasic local alignment search toolrdquo Journal ofMolecular Biologyvol 215 no 3 pp 403ndash410 1990
[14] J D D Pitout ldquoMultiresistant enterobacteriaceae new threat ofan old problemrdquo Expert Review of Anti-InfectiveTherapy vol 6no 5 pp 657ndash669 2008
[15] J Manuel R Martinez P Nordmann N Fortineau and LPoirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[16] J-M Rodriguez-Martinez P Nordmann N Fortineau andL Poirel ldquoVIM-19 a metallo-120573-lactamase with increased car-bapenemase activity from Escherichia coli and Klebsiella pneu-moniaerdquo Antimicrobial Agents and Chemotherapy vol 54 no 1pp 471ndash476 2010
[17] M Shanthi and U Sekar ldquoExtended spectrum beta lactamaseproducing Escherichia coli and Klebsiella pneumoniae riskfactors for infection and impact of resistance on outcomesrdquoJournal of the Association of Physicians of India vol 58 no 1pp 41ndash44 2010
[18] K K BenachinmardiM Padmavathy JMalini and B V Nave-neeth ldquoPrevalence of non-fermenting Gram-negative bacilliand their in vitro susceptibility pattern at a tertiary care teachinghospitalrdquo Journal of the Scientific Society vol 41 no 3 pp 162ndash166 2014
[19] S K Sahu A S Dalal and G Bansal ldquoDetection of extended-spectrum 120573-lactamases in clinical isolates of E coli and Kleb-siella species fromUdaipurRajasthanrdquoBiomedical Research vol22 no 3 pp 367ndash373 2011
[20] K Vipin K M Rohit C Avantika and G Pramila ldquoIncidenceof 120573-lactamase producing gram-negative clinical isolates andtheir antibiotic susceptibility pattern a case study inAllahabadrdquoInternational Journal of Research in Pure and Applied Microbiol-ogy vol 1 no 3 pp 36ndash39 2011
[21] J Sankarankutty and S Kaup ldquoMicrobiological profile andantibiogram of uropathogens from a tertiary care centre inTumkur Indiardquo Journal of Microbiology and BiotechnologyResearch vol 4 no 2 pp 46ndash51 2014
[22] O A Aboderin L-R Abdu BWOdetoyin and A LamikanraldquoAntimicrobial resistance in Escherichia coli strains from uri-nary tract infectionsrdquo Journal of the National Medical Associa-tion vol 101 no 12 pp 1268ndash1273 2009
[23] S H Kumar A S De SM Baveja andMA Gore ldquoPrevalenceand risk factors ofMetallo120573-lactamase producingPseudomonasaeruginosa and Acinetobacter species in burns and surgicalwards in a tertiary care hospitalrdquo Journal of Laboratory Physi-cians vol 4 no 1 pp 39ndash42 2012
[24] Z Aktas D Satana C Kayacan et al ldquoCarbapenem resistancein Turkey repeat report on OXA-48 in Klebsiella pneumoniaeand first report on IMP-1 beta-lactamase in Escherichia colirdquoAfrican Journal ofMicrobiology Research vol 6 no 17 pp 3874ndash3878 2012
[25] F F Tuon J L Rocha P Toledo et al ldquoRisk factors for KPC-producingKlebsiella pneumoniae bacteremiardquo Brazilian Journalof Infectious Diseases vol 16 no 5 pp 416ndash419 2012
[26] K Prashanth and S Badrinath ldquoIn vitro susceptibility patternof Acinetobacter species to commonly used cephalosporins
quinolones and aminoglycosidesrdquo Indian Journal of MedicalMicrobiology vol 22 no 2 pp 97ndash103 2004
[27] N M Mohamed and D Raafat ldquoPhenotypic and genotypicdetection of metallo-beta-lactamases in imipenem-resistantAcinetobacter baumannii isolated from a tertiary hospital inAlexandria Egyptrdquo Research Journal of Microbiology vol 6 no10 pp 750ndash760 2011
[28] A Poulou E Voulgari G Vrioni et al ldquoImported Klebsiellapneumoniae carbapenemase-producing K pneumoniae clonesin a Greek hospital Impact of infection control measures forrestraining their disseminationrdquo Journal of Clinical Microbiol-ogy vol 50 no 8 pp 2618ndash2623 2012
[29] S M Al Johani J Akhter H Balkhy A El-Saed M Younanand Z Memish ldquoPrevalence of antimicrobial resistance amonggram-negative isolates in an adult intensive care unit at a tertiarycare center in Saudi Arabiardquo Annals of Saudi Medicine vol 30no 5 pp 364ndash369 2010
[30] I Galani P D Rekatsina D Hatzaki D Plachouras M SouliandH Giamarellou ldquoEvaluation of different laboratory tests forthe detection of metallo-120573-lactamase production in Enterobac-teriaceaerdquo Journal of Antimicrobial Chemotherapy vol 61 no 3pp 548ndash553 2008
[31] F Shahcheraghi V S Nikbin and M M Feizabadi ldquoIdentifi-cation and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran IranrdquoNew Microbiologica vol 33 no 3 pp 243ndash248 2010
[32] F Shahcheraghi M Abbasalipour M M Feizabadi G HEbrahimipour and N Akbari ldquoIsolation and genetic character-ization of metallo-120573-lactamase and carbapenamase producingstrains of Acinetobacter baumannii from patients at tehranhospitalsrdquo Iranian Journal of Microbiology vol 3 no 2 pp 68ndash74 2011
[33] A A Shah F Hasan S Ahmed and A Hameed ldquoCharac-teristics epidemiology and clinical importance of emergingstrains of Gram-negative bacilli producing extended-spectrum120573-lactamasesrdquoResearch inMicrobiology vol 155 no 6 pp 409ndash421 2004
[34] F EftekharM RastegarM Golalipoor andNMansoursamaeildquoDetection of extended spectrum Β-lactamases in urinaryisolates of Klebsiella pneumoniae in relation to 119861119897119886SHV 119861119897119886TEMand 119861119897119886CTX-M gene carriagerdquo Iranian Journal of Public Healthvol 41 no 3 pp 127ndash132 2012
[35] D Ojdana P Sacha P Wieczorek et al ldquoThe occurrence of119887119897119886CTX-M 119887119897119886SHV and 119887119897119886TEM genes in extended-spectrum 120573-lactamase-positive strains ofKlebsiella pneumoniae Escherichiacoli and Proteus mirabilis in Polandrdquo International Journal ofAntibiotics vol 2014 Article ID 935842 7 pages 2014
[36] G Cuzon T Naas P Bogaerts Y Glupczynski and P Nord-mann ldquoEvaluation of a DNAmicroarray for the rapid detectionof extended-spectrum 120573-lactamases (TEM SHV and CTX-M)plasmid-mediated cephalosporinases (CMY-2-like DHA FOXACC-1 ACTMIR and CMY-1-likeMOX) and carbapenemases(KPCOXA-48VIM IMPandNDM)rdquo Journal of AntimicrobialChemotherapy vol 67 no 8 Article ID dks156 pp 1865ndash18692012
[37] K Zurfluh H HachlerM Nuesch-Inderbinen and R StephanldquoCharacteristics of extended-spectrum 120573-lactamase- andcarbapenemase-producing Enterobacteriaceae isolates fromrivers and lakes in Switzerlandrdquo Applied and EnvironmentalMicrobiology vol 79 no 9 pp 3021ndash3026 2013
[38] R H Pokhrel B Thapa R Kafle P K Shah and C Tribud-dharat ldquoCo-existence of beta-lactamases in clinical isolates of
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
International Journal of Microbiology 15
Escherichia coli from Kathmandu Nepalrdquo BMC Research Notesvol 7 article 694 2014
[39] H Alsayed Gaber M A Ahmed B M Rania M Mohammedand M A Osama ldquoMathematical modeling and classificationof viruses from herpesvirus familyrdquo International Journal ofComputer Applications vol 87 no 12 pp 5ndash13 2014
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology
Submit your manuscripts athttpwwwhindawicom
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Anatomy Research International
PeptidesInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporation httpwwwhindawicom
International Journal of
Volume 2014
Zoology
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Molecular Biology International
GenomicsInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
The Scientific World JournalHindawi Publishing Corporation httpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioinformaticsAdvances in
Marine BiologyJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Signal TransductionJournal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
BioMed Research International
Evolutionary BiologyInternational Journal of
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Biochemistry Research International
ArchaeaHindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Genetics Research International
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporationhttpwwwhindawicom
Nucleic AcidsJournal of
Volume 2014
Stem CellsInternational
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
Enzyme Research
Hindawi Publishing Corporationhttpwwwhindawicom Volume 2014
International Journal of
Microbiology